Lyphochek Assayed Chemistry Control Levels 1 and 2: Tanggal Revisi 2020-06-15 Menunjukkan Informasi Yang Direvisi

Lyphochek® Assayed Chemistry Control
Levels 1 and 2
C-310-5 Level 1 12 x 5 mL Level 1 26461
C-315-5 Level 2 12 x 5 mL 2022-07-31 26460 Level 2 26462
313X MiniPak 2 x 5 mL
http://www.myeinserts.com/26460
Tanggal Revisi 2020-06-15 Menunjukkan Informasi yang Direvisi
METODE (1)
Level 1 - 26461 Level 2 - 26462
Unit Rata-rata Rentang Rata-rata Rentang
ACID PHOSPHATASE (TOTAL) (2)
Accurex Biomedical (a-naphthyl phosphate) (4) U/L § §
Colorimetric Test Substrate Naphytl. Pentandiol U/L 21.4 7.76 – 35.1 44.3 20.3 – 68.2
ALBUMIN
Accurex Biomedical (Bromocresol green) (4) g/dL 4.26 3.47 – 5.05 2.89 2.23 – 3.55
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) g/dL 4.20 3.64 – 4.81 3.20 2.70 – 3.70
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) g/dL 3.95 3.30 – 4.60 3.09 2.60 – 3.60
Agappe Diagnostics Ltd. (MISPA CCXL) (4) g/dL 4.10 3.30 – 4.90 3.00 2.40 – 3.60
Agappe Diagnostics Ltd. (MISPA NANO) (4) g/dL 4.10 3.60 – 4.60 3.30 2.70 – 3.90
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) g/dL 4.20 3.57 – 4.90 3.20 2.68 – 3.73
Agappe Diagnostics Ltd. (Toshiba TBA-120FR) (4) g/dL
Bromcresol green (3) g/dL 4.19 3.72 – 4.65 2.73 2.40 – 3.07
Catechem ChemWell-T (Bromcresol green) (4) g/dL 4.30 3.10 – 5.50 3.70 3.10 – 4.30
Fortress Diagnostics (Bromcresol green) (BXC0222) (4) g/dL 4.09 3.48 – 4.71 2.70 2.30 – 3.11
Sekisui Medical Clinimate, Autosera (Dye Binding-BCG) (4) g/dL 4.06 3.76 – 4.36 2.67 2.37 – 2.97
Teco Diagnostics TC-Matrix (Bromcresol green) (4) g/dL § §
ALKALINE PHOSPHATASE (2)
Accurex Biomedical (p-NPP, DEA Buffer) (4) U/L 160 112 – 207 564 485 – 643
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) U/L 166 82.3 – 250 550 427 – 673
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia - IFCC) (4) U/L 121 94.6 – 148 479 406 – 552
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) U/L 153 113 – 194 473 379 – 568
Agappe Diagnostics Ltd. (MISPA CCXL - IFCC) (4) U/L 105 80.0 – 130 426 320 – 531
Agappe Diagnostics Ltd. (MISPA CCXL) (4) U/L 125 80.4 – 169 463 369 – 557
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 153 113 – 193 517 406 – 628
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) U/L 161 119 – 202 551 457 – 646
Agappe Diagnostics Ltd. (Toshiba TBA-25FR) (4) U/L
Catachem ChemWell-T (4) U/L 105 77.0 – 133 408 309 – 507
Fortress Diagnostics (AMP) (BXC0184) (4) U/L 126 107 – 145 487 414 – 561
Fortress Diagnostics (DEA) (BXC0185) (4) U/L 219 186 – 251 715 608 – 822
PNPP, AMP Buffer (3) U/L 111 81.5 – 139 456 380 – 532
Sekisui Medical Pureauto S, Autosera S, Qualigent ALP (4) U/L 284 259 – 309 957 887 – 1027
Teco Diagnostics TC-Matrix (Modified Bowers-McComb Liquid) (4) U/L § §
ALT/SGPT (2)
Accurex Biomedical (IFCC, UV Kinetic, without P5P) (4) U/L 29.0 19.4 – 38.6 86.9 68.3 – 106
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) U/L 28.1 20.4 – 35.9 102 76.9 – 126
Halaman 1 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00
8
Lyphochek® Assayed Chemistry Control, Levels 1 and 2
METODE (1)
Level 1 - 26461 Level 2 - 26462
ALT/SGPT (2) (terus menerus)
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) U/L 26.8 18.9 – 34.6 102 79.9 – 123
Agappe Diagnostics Ltd. (MISPA CCXL) (4) U/L 26.4 17.3 – 35.5 102 79.3 – 124
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 28.2 20.7 – 35.7 102 77.0 – 126
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) U/L 28.8 21.0 – 36.6 106 84.4 – 128
Catachem ChemWell-T (4) U/L 28.0 20.0 – 36.0 99.0 75.0 – 123
Fortress Diagnostics (IFCC UV Liquid) (BXCO213) (4) U/L 28.4 24.2 – 32.7 101 85.6 – 116
IFCC 2002 (UV with P5P) (3) U/L 29.3 23.0 – 35.6 104 89.5 – 118
IFCC 2002 (UV without P5P) (3) U/L 28.9 22.4 – 35.3 98.6 85.8 – 111
Sekisui Medical Pureauto S, Qualigent (ALT-L) (UV without P5P) (4) U/L 29.0 24.0 – 34.0 101 89.3 – 113
Teco Diagnostics TC-Matrix (Optimized Tris Liquid) (4) U/L § §
AMYLASE (2)
Accurex Biomedical (Gal G2 a-CNP) (4) U/L 76.0 51.6 – 100 502 421 – 583
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) U/L 61.1 51.1 – 71.1 462 376 – 547
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia - Jaffe) (4) U/L 57.2 48.1 – 66.3 460 384 – 536
Agappe Diagnostics Ltd. (MISPA CCXL) (4) U/L 61.8 50.0 – 73.6 452 373 – 531
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 59.4 49.0 – 69.8 456 376 – 537
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) U/L 63.9 54.8 – 73.0 466 390 – 542
Catachem ChemWell-T (4) U/L 72.0 47.0 – 97.0 503 389 – 617
EPS-G7 (3) U/L 79.5 69.1 – 90.0 415 383 – 447
Fortress Diagnostics (CNPG3) (BXC0562) (4) U/L 64.2 54.6 – 73.8 377 320 – 433
Fortress Diagnostics (EPS) (BXC0563) (4) U/L 53.7 45.6 – 61.7 360 306 – 414
Sekisui Medical Pureauto S, Qualigent AMY-G2 (4) U/L 90.8 85.8 – 95.8 609 589 – 629
Teco Diagnostics TC-Matrix (4) U/L § §
Teco Diagnostics TC-Matrix (Kinetic) (4) U/L § §
AMYLASE (PANCREATIC) (2)
EPS-G7 Liquid (3) U/L 44.6 34.3 – 54.8 374 352 – 395
Sekisui Medical Pureauto S, Qualigent P-AMY-G2 (4) U/L 59.7 54.7 – 64.7 554 529 – 579
AST/SGOT (2)
Accurex Biomedical (IFCC, UV Kinetic, without P5P) (4) U/L 38.3 25.9 – 50.7 187 148 – 226
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) U/L 37.4 29.2 – 45.5 218 170 – 266
Agappe Diagnostics Ltd. (MISPA CCXL) (4) U/L 39.1 29.1 – 49.1 217 167 – 267
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 42.9 33.9 – 52.0 225 181 – 270
Catachem ChemWell-T (4) U/L 33.0 21.0 – 45.0 164 112 – 216
Fortress Diagnostics (IFCC UV Liquid) (BXCO203) (4) U/L 41.2 35.0 – 47.4 210 178 – 241
IFCC 2002 (UV with P5P) (3) U/L 41.6 34.0 – 49.1 215 189 – 242
IFCC 2002 (UV without P5P) (3) U/L 39.3 31.8 – 46.8 196 172 – 220
Sekisui Medical Pureauto S, Qualigent AST-L (UV without P5P) (4) U/L 42.0 37.0 – 47.0 216 204 – 228
Teco Diagnostics TC-Matrix (Optimized Tris Liquid) (4) U/L § §
BILIRUBIN (DIRECT)
Accurex Biomedical (Jendrassik Grof, DMSO) (4) mg/dL 0.360 0.220 – 0.500 1.29 0.810 – 1.77
Advanced Instruments BR2 Bilirubin Stat-Analyzer (Photometric) (4) mg/dL 0.200 0.100 – 0.300 0.800 0.400 – 1.20
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mg/dL
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) mg/dL
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 0.300 0.100 – 0.500 0.700 0.300 – 1.10
8
METODE (1)
Level 1 - 26461 Level 2 - 26462
BILIRUBIN (DIRECT) (terus menerus)
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mg/dL
Agappe Diagnostics Ltd. (Toshiba TBA-25FR) (4) mg/dL
Catachem ChemWell-T (4) mg/dL
Diazotization / DPD / Jendrassik Grof (3) mg/dL 0.288 0.147 – 0.428 1.12 0.856 – 1.39
Fortress Diagnostics (Jendrassik Grof) (BXC0191) (4) mg/dL 0.561 0.477 – 0.646 1.16 0.985 – 1.33
Teco Diagnostics TC-Matrix (Diazotization) (4) mg/dL § §
Vanadate Oxidation (3) mg/dL § §
Wako L-Type (AU480) (4) mg/dL 0.329 0.306 – 0.352 1.32 1.09 – 1.55
BILIRUBIN (TOTAL)
Accurex Biomedical (Jendrassik Grof, DMSO) (4) mg/dL 0.870 0.560 – 1.18 4.18 3.40 – 4.96
Advanced Instruments BR2 Bilirubin Stat-Analyzer (Photometric) (4) mg/dL 1.75 1.40 – 2.10 4.41 3.50 – 5.30
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mg/dL
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) mg/dL 0.930 0.700 – 1.20 4.32 3.40 – 5.20
Agappe Diagnostics Ltd. (MISPA CCXL) (4) mg/dL
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mg/dL
Catachem ChemWell-T (4) mg/dL 0.840 0.500 – 1.18 4.09 3.31 – 4.87
DPD (3) mg/dL § §
Fortress Diagnostics (Jendrassik Grof) (BXC0192) (4) mg/dL 1.13 0.960 – 1.30 3.87 3.29 – 4.46
Jendrassik Grof (3) mg/dL 0.993 0.691 – 1.29 4.29 3.69 – 4.88
Teco Diagnostics TC-Matrix (Sulphanilic acid, DMSO) (4) mg/dL § §
Vanadate Oxidation (3) mg/dL § §
CALCIUM
Accurex Biomedical (Arsenazo III) (4) mg/dL 9.28 7.90 – 10.7 11.7 10.3 – 13.1
Accurex Biomedical (o-cresolphthalein complexone) (4) mg/dL 9.20 7.52 – 10.9 11.9 10.5 – 13.3
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mg/dL 9.10 7.76 – 10.5 10.5 7.70 – 13.4
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) mg/dL 9.36 8.30 – 10.4 11.8 10.4 – 13.2
Agappe Diagnostics Ltd. (MISPA CCXL) mg/dL 9.60 8.40 – 10.7 11.9 10.2 – 13.5
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mg/dL 9.80 8.82 – 10.8 12.3 10.5 – 14.1
Arsenazo III (3) mg/dL 9.55 8.50 – 10.6 11.9 10.7 – 13.1
Fortress Diagnostics (Arsenazo III) (BXC0292) (4) mg/dL 9.80 8.32 – 11.3 11.9 10.1 – 13.7
Fortress Diagnostics (OCPC) (BXC0291) (4) mg/dL 8.68 7.40 – 10.0 11.6 9.88 – 13.4
o-cresolphthalein complexone (3) mg/dL 9.04 8.18 – 9.91 12.1 11.0 – 13.2
Sekisui Medical Clinimate, Qualigent CA (4) mg/dL 8.80 7.90 – 9.70 11.7 10.5 – 12.9
Teco Diagnostics TC-Matrix (Arsenazo III) (4) mg/dL § §
Teco Diagnostics TC-Matrix (o-cresolphthalein complexone) (4) mg/dL § §
CALCIUM (IONIZED)
ISE Direct (3) mg/dL § §
CARBON DIOXIDE (CO2)
Teco Diagnostics TC-Matrix (Enzymatic) (4) mEq/L § §
CHLORIDE
Accurex Biomedical (Mercuric Thiocyanate) (4) mEq/L 92.3 81.2 – 103 82.9 73.5 – 92.3
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mEq/L 96.4 86.3 – 106 89.5 79.1 – 100
Agappe Diagnostics Ltd. (MISPA CCXL) (4) mEq/L 96.7 87.2 – 106 87.5 78.2 – 96.7
8
METODE (1)
Level 1 - 26461 Level 2 - 26462
CHLORIDE (terus menerus)
Agappe Diagnostics Ltd. (MISPA NANO) (4) mEq/L 95.6 85.3 – 106 88.7 74.6 – 103
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mEq/L 98.3 89.0 – 108 89.8 81.1 – 98.5
Agappe Diagnostics Ltd. (Toshiba TBA-25FR) (4) mEq/L
Fortress Diagnostics (Thiocyanate) (BXC0281) (4) mEq/L 106 89.9 – 122 92.8 78.9 – 107
ISE Indirect (3) mEq/L 105 97.2 – 112 88.1 82.5 – 93.7
Sekisui Medical Internal Standard Solution -K/-B, Dilutent -K/-B (4) mEq/L 107 100 – 114 86.9 81.9 – 91.9
Teco Diagnostics TC-Matrix (Mercuric Thiocyanate) (4) mEq/L § §
CHOLESTEROL (HDL) (2)
Accurex Biomedical (Direct Homogenous-Autopure) (4) mg/dL 80.2 63.3 – 97.1 29.9 19.8 – 40.0
Agappe Diagnostics Ltd. (MISPA CCXL) (4) mg/dL 52.5 42.3 – 62.7 23.3 16.8 – 29.8
Direct measure (3) mg/dL 70.2 54.4 – 85.9 28.9 20.1 – 37.7
Fortress Diagnostics (Direct) (BXC0421) (4) mg/dL 72.6 61.8 – 83.4 30.1 25.5 – 34.7
Sekisui Medical Cholestest N, Qualigent N HDL (4) mg/dL 75.7 66.7 – 84.7 31.6 27.6 – 35.6
CHOLESTEROL (LDL)
Accurex Biomedical (Direct Homogenous-Autopure) (4) mg/dL 129 100 – 158 56.7 38.2 – 75.2
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mg/dL 154 139 – 168 68.7 53.7 – 83.7
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) mg/dL 143 125 – 161 66.0 51.8 – 80.2
Agappe Diagnostics Ltd. (MISPA CCXL) (4) mg/dL 150 129 – 170 65.0 51.4 – 78.7
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 137 110 – 163 59.8 43.1 – 76.6
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mg/dL 155 134 – 175 70.6 56.3 – 85.0
Direct measure (3) mg/dL 139 115 – 163 63.1 50.1 – 76.1
Fortress Diagnostics (Direct) (BXC0431) (4) mg/dL 132 112 – 151 58.7 49.8 – 67.6
Sekisui Medical Cholestest, Qualigent LDL (4) mg/dL 133 124 – 142 60.9 55.9 – 65.9
Wako L-Type (AU480) (4) mg/dL 147 140 – 154 71.8 69.7 – 73.9
CHOLESTEROL (TOTAL)
Accurex Biomedical (Cholesterol oxidase-Peroxidase) (4) mg/dL 240 202 – 278 113 93.6 – 132
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mg/dL 256 200 – 312 106 87.4 – 125
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) mg/dL 248 203 – 293 107 93.0 – 121
Agappe Diagnostics Ltd. (MISPA CCXL) (4) mg/dL 247 180 – 313 107 88.7 – 126
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 254 200 – 308 105 86.8 – 123
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mg/dL 258 207 – 309 108 93.6 – 123
CHOD-PAP (3) mg/dL 249 225 – 272 102 89.7 – 114
Fortress Diagnostics (CHOD-PAP Liquid) (BXC0261) (4) mg/dL 251 213 – 288 107 90.7 – 123
Sekisui Medical Cholestest, Qualigent CHO (4) mg/dL 253 241 – 265 109 98.7 – 119
Sekisui Medical Pureauto S CHO-N (4) mg/dL 254 242 – 266 109 98.5 – 119
Teco Diagnostics TC-Matrix (Enzymatic Liquid) (4) mg/dL § §
CHOLINESTERASE (2)
Accurex Biomedical (Butyrylthiocholine) (4) U/L 6866 6037 – 7695 4106 3425 – 4787
Butyrylthiocholine (3) U/L 9295 6066 – 12524 5341 3637 – 7045
Fortress Diagnostics (Butyrylthiocholine DGKC) (BXC0801) (4) U/L 7851 6673 – 9029 4180 3553 – 4807
8
METODE (1)
Level 1 - 26461 Level 2 - 26462
COMPLEMENT C3
Sekisui Medical (Immunotesta C3) (4) mg/dL § §
COPPER
Atomic Absorption µg/dL 109 82.7 – 135 69.2 48.1 – 90.2
Fortress Diagnostics (Colorimetric, End Point) (BXC0341) (4) µg/dL 51.8 44.1 – 59.6 34.8 29.6 – 40.0
CREATINE KINASE (CK) (2)
Accurex Biomedical (NAC activated) (4) U/L 105 67.0 – 143 388 310 – 466
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) U/L 137 117 – 157 472 383 – 561
Agappe Diagnostics Ltd. (MISPA CCXL) (4) U/L 129 109 – 148 415 335 – 496
Catachem ChemWell-T (4) U/L 143 109 – 177 512 417 – 607
Fortress Diagnostics (NAC Activated Liquid) (BXCO252) (4) U/L 130 111 – 150 445 379 – 512
IFCC 2002 (3) U/L 139 116 – 162 453 400 – 505
Sekisui Medical Pureauto S CK (4) U/L 137 117 – 157 442 412 – 472
Sekisui Medical Pureauto S, Qualigent CK-L (4) U/L 136 116 – 156 448 418 – 478
Teco Diagnostics TC-Matrix (UV Kinetic) (4) U/L § §
CREATININE
Accurex Biomedical (Jaffe, Kinetic) (4) mg/dL 1.90 1.29 – 2.51 5.48 4.52 – 6.44
Agappe Diagnostics Ltd. (Biolis/TMS Series - Enzymatic) (4) mg/dL 1.80 1.35 – 2.35 5.60 4.90 – 6.40
Agappe Diagnostics Ltd. (Biolis/TMS Series - Jaffe) (4) mg/dL 2.10 1.84 – 2.39 5.00 4.10 – 5.90
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia - Enzymatic) (4) mg/dL 1.79 1.30 – 2.30 5.46 4.70 – 6.20
Agappe Diagnostics Ltd. (MISPA CCXL - Enzymatic) (4) mg/dL 1.80 1.30 – 2.30 5.30 4.50 – 6.00
Agappe Diagnostics Ltd. (MISPA NANO - Enzymatic) (4) mg/dL 1.90 1.40 – 2.40 5.60 4.90 – 6.40
Agappe Diagnostics Ltd. (MISPA NANO - Jaffe) (4) mg/dL 2.10 1.60 – 2.60 4.90 4.10 – 5.70
Agappe Diagnostics Ltd. (Toshiba TBA Series - Enzymatic) (4) mg/dL 1.90 1.36 – 2.45 5.80 5.05 – 6.58
Agappe Diagnostics Ltd. (Toshiba TBA Series - Jaffe) (4) mg/dL 2.30 1.70 – 2.87 5.10 4.43 – 5.76
Agappe Diagnostics Ltd. (Toshiba TBA-25FR - Enzymatic) (4) mg/dL
Agappe Diagnostics Ltd. (Toshiba TBA-25FR - Jaffe) (4) mg/dL
Alkaline picrate-kinetic (3) mg/dL 2.37 1.93 – 2.81 5.78 5.08 – 6.48
Enzymatic (3) mg/dL 2.04 1.54 – 2.55 5.54 4.95 – 6.14
Fortress Diagnostics (Enzymatic) (BXC0113) (4) mg/dL 1.85 1.57 – 2.13 5.33 4.53 – 6.13
Fortress Diagnostics (Jaffe) (BXC0111) (4) mg/dL 2.61 2.22 – 3.01 5.76 4.90 – 6.63
Sekisui Medical Clinimate CRE (4) mg/dL 2.39 2.09 – 2.69 5.75 5.15 – 6.35
Sekisui Medical Pureauto S CRE-L (4) mg/dL 1.77 1.57 – 1.97 5.24 4.99 – 5.49
Sekisui Medical Pureauto S, Qualigent CRE-N (4) mg/dL 1.83 1.63 – 2.03 5.40 5.15 – 5.65
Teco Diagnostics TC-Matrix (Jaffe Kinetic) (4) mg/dL § §
GAMMA GLUTAMYLTRANSFERASE (GGT) (2)
Accurex Biomedical (IFCC) (4) U/L 55.7 40.8 – 70.6 131 107 – 155
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) U/L 48.7 38.3 – 59.1 133 98.8 – 168
Agappe Diagnostics Ltd. (MISPA CCXL) (4) U/L 49.4 36.3 – 62.4 130 98.7 – 162
Agappe Diagnostics Ltd. (MISPA NANO) (4) U/L 53.4 42.5 – 64.2 137 99.2 – 175
8
METODE (1)
Level 1 - 26461 Level 2 - 26462
GAMMA GLUTAMYLTRANSFERASE (GGT) (2) (terus menerus)
Fortress Diagnostics (Glycylglycine Liquid) (BXC0362) (4) U/L 58.7 49.9 – 67.5 147 125 – 170
IFCC 2002 (3) U/L 66.4 52.1 – 80.6 169 136 – 202
Sekisui Medical Pureauto S GGT (4) U/L 64.9 59.9 – 69.9 169 154 – 184
Sekisui Medical Pureauto S, Qualigent y-GT (4) U/L 65.6 60.6 – 70.6 173 158 – 188
Teco Diagnostics TC-Matrix (Kinetic Liquid) (4) U/L § §
GLUCOSE
Accurex Biomedical (Glucose oxidase-Peroxidase) (4) mg/dL 81.2 63.1 – 99.3 268 237 – 299
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mg/dL 80.5 69.8 – 91.2 280 239 – 320
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) mg/dL 78.9 70.5 – 87.2 270 232 – 308
Agappe Diagnostics Ltd. (MISPA CCXL - Hexokinase) (4) mg/dL 77.6 67.2 – 88.0 273 241 – 305
Agappe Diagnostics Ltd. (MISPA CCXL) (4) mg/dL 79.1 69.5 – 88.8 270 231 – 308
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 81.7 71.1 – 92.3 276 238 – 314
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mg/dL 81.4 73.2 – 89.5 275 236 – 315
Dr. Mueller Geraetebau GmbH, SUPER G1, SUPER G2, SUPER GL Serie (4) mg/dL § §
EKF und Eppendorf (BIOSEN-, EBIO basic -und EBIO compact -Analysatoren)
GOD (4) mg/dL 83.2 74.1 – 92.4 275 245 – 305
Fortress Diagnostics (GOD-PAP) (BXC0101) (4) mg/dL 83.2 70.8 – 95.9 284 241 – 326
Fortress Diagnostics (Hexokinase) (BXC0103) (4) mg/dL 101 85.6 – 116 293 249 – 337
GOD-POD (3) mg/dL 87.5 73.5 – 102 271 240 – 303
Hexokinase (3) mg/dL 84.0 74.4 – 93.6 276 253 – 298
Kabe Labortechnik GmbH (GA 2/3 mit Dickschichtelectrode-DSE) (4) mg/dL 83.4 74.5 – 92.5 280 249 – 310
Sekisui Medical Pureauto S GLU (4) mg/dL 86.8 80.8 – 92.8 278 263 – 293
Sekisui Medical Pureauto S, Qualigent GLU-R (4) mg/dL 82.9 76.9 – 88.9 281 266 – 296
Teco Diagnostics TC-Matrix (Glucose Oxidase Liquid) (4) mg/dL § §
Teco Diagnostics TC-Matrix (Hexokinase Liquid) (4) mg/dL § §
GLUTAMATE DEHYDROGENASE (GLDH) (2) (3)
DiaSys U/L 6.86 5.97 – 7.74 13.6 11.9 – 15.3
Standard Method without Correction for the Non-Specific Creep Reaction U/L 6.77 5.85 – 7.69 13.3 11.5 – 15.1
HAPTOGLOBIN
Immunoturbidimetric (3) mg/dL 124 108 – 139 85.3 73.9 – 96.7
IMMUNOGLOBULIN A (IGA)
Immunoturbidimetric (3) mg/dL 193 165 – 220 124 100 – 148
Sekisui Medical Pureauto S IgA (4) mg/dL 196 181 – 211 130 120 – 140
IMMUNOGLOBULIN G (IGG)
Sekisui Medical Pureauto S IgG (4) mg/dL § §
IMMUNOGLOBULIN M (IGM)
Immunoturbidimetric (3) mg/dL 80.4 61.5 – 99.3 44.7 29.8 – 59.6
Sekisui Medical Pureauto S IgM (4) mg/dL 88.6 78.6 – 98.6 53.0 48.0 – 58.0
IRON
Ferrozine (3) µg/dL 231 212 – 250 67.9 57.8 – 78.0
Fortress Diagnostics (Ferene) (BXC0232) (4) µg/dL 213 181 – 244 65.6 55.8 – 75.4
Fortress Diagnostics (Ferrozine) (BXC0235) (4) µg/dL 226 192 – 260 76.4 64.9 – 87.8
Teco Diagnostics TC-Matrix (Ferrozine) (4) µg/dL § §
IRON (TIBC)
Fortress Diagnostics (BXC0237) (4) µg/dL 316 268 – 363 205 174 – 235
8
METODE (1)
Level 1 - 26461 Level 2 - 26462
IRON (UIBC)
Sekisui Medical Pureauto S UIBC (4) µg/dL 100 85.0 – 115 149 134 – 164
LACTATE (LACTIC ACID)
Dr. Mueller Geraetebau GmbH, SUPER G1, SUPER G2, SUPER GL Serie (4) mg/dL
EKF und Eppendorf (BIOSENS-, EBIObasic-und EBIOcompact-Analysatoren) LOD
(4) mg/dL 39.2 34.9 – 43.5 10.4 9.28 – 11.5
Enzymatic (3) mg/dL 37.9 34.0 – 41.8 9.31 7.32 – 11.3
Fortress Diagnostics (Enzymatic, colorimetric) (BXC0622) (4) mg/dL 40.3 34.2 – 46.3 8.74 7.39 – 10.1
LACTATE DEHYDROGENASE (LDH) (2)
Accurex Biomedical (P-L, UV Kinetic) (4) U/L 349 280 – 418 787 688 – 886
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) U/L 370 278 – 461 894 790 – 998
Agappe Diagnostics Ltd. (MISPA CCXL) (4) U/L 347 264 – 430 839 752 – 925
Fortress Diagnostics (L-P) (BXC0243) (4) U/L 174 148 – 200 373 317 – 428
Fortress Diagnostics (P-L) (BXC0242) (4) U/L 310 264 – 357 741 630 – 852
IFCC 2002 (3) U/L § §
Sekisui Medical Pureauto S LD, Qualigent LD (4) U/L 172 162 – 182 372 352 – 392
Sekisui Medical Pureauto S LD-P (4) U/L 385 365 – 405 887 837 – 937
Teco Diagnostics TC-Matrix (Modified Wacker Tris, Kinetic) (Liquid) (4) U/L § §
LAP ARYLAMIDASE (2)
Sekisui Medical Pureauto LAP (4) U/L 44.3 38.5 – 50.3 28.5 25.5 – 31.5
LIPASE (2)
Accurex Biomedical (Colorimetric) (4) U/L 43.9 34.0 – 53.8 71.6 52.0 – 91.2
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) U/L 46.2 32.9 – 59.6 68.8 54.3 – 83.3
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) U/L 44.0 35.7 – 52.3 68.6 57.0 – 80.1
ANALYTICON/Biocon: Fluitest Lipase (Colorimetric) (4) U/L 46.0 39.1 – 52.9 73.8 62.7 – 84.9
Colorimetric (3) U/L 197 170 – 224 321 282 – 360
Enzymatic, colorimetric (3) U/L 46.5 39.1 – 53.9 82.3 70.9 – 93.7
Fortress Diagnostics (BXC0511) (4) U/L 58.1 49.4 – 66.8 107 91.1 – 123
LITHIUM
Atomic Absorption mEq/L 0.583 0.502 – 0.664 1.72 1.50 – 1.95
Flame Photometry mEq/L § §
MAGNESIUM
Accurex Biomedical (Xylidyl blue) (4) mg/dL 2.18 1.60 – 2.76 4.21 3.27 – 5.15
Atomic Absorption mg/dL § §
Catachem ChemWell-T (4) mg/dL 2.00 1.58 – 2.42 2.90 1.98 – 3.82
Fortress Diagnostics (Xylidyl blue) (BXC0352) (4) mg/dL 1.90 1.60 – 2.16 4.25 3.62 – 4.89
Sekisui Medical Clinimate MG (4) mg/dL 2.13 1.83 – 2.43 4.52 4.12 – 4.92
Teco Diagnostics TC-Matrix (Calmagite) (4) mg/dL § §
Teco Diagnostics TC-Matrix (Xylidyl blue) (4) mg/dL § §
8
METODE (1)
Level 1 - 26461 Level 2 - 26462
MAGNESIUM (terus menerus)
Xylidyl blue (3) mg/dL 2.02 1.62 – 2.42 4.33 3.70 – 4.95
OSMOLALITY
Freezing Point Depression mOSM/kg 568 536 – 601 482 456 – 508
PHOSPHORUS
Accurex Biomedical (Ammonium Molybdate, UV Endpoint) (4) mg/dL 3.65 2.97 – 4.33 7.35 6.32 – 8.38
Fortress Diagnostics (UV Molybdate) (BXC0301) (4) mg/dL 3.41 2.88 – 3.90 7.15 6.07 – 8.24
Phosphomolybdate-UV (3) mg/dL 3.35 2.93 – 3.77 7.49 6.85 – 8.14
Sekisui Medical Clinimate IP-2 (4) mg/dL 3.32 3.02 – 3.62 7.36 6.36 – 8.36
Teco Diagnostics TC-Matrix (Molybdenum UV) (4) mg/dL § §
POTASSIUM
Flame Photometry mEq/L § §
Fortress Diagnostics (Colorimetric) (BXC0138) (4) mEq/L 4.14 3.52 – 4.76 5.86 4.98 – 6.74
ISE Indirect (3) mEq/L 3.88 3.65 – 4.12 6.23 5.92 – 6.55
Sekisui Medical Internal Standard Solution -K/-B, Dilutent -K/-B (4) mEq/L 4.03 3.83 – 4.23 6.39 5.89 – 6.89
Teco Diagnostics TC-Matrix (Turbidimetric) (4) mEq/L § §
PROTEIN SERUM (TOTAL)
Accurex Biomedical (Biuret) (4) g/dL 6.54 5.66 – 7.42 4.40 3.66 – 5.14
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) g/dL 6.60 5.68 – 7.56 4.40 3.90 – 4.90
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) g/dL 6.64 5.80 – 7.50 4.26 3.80 – 4.70
Agappe Diagnostics Ltd. (MISPA CCXL) (4) g/dL 6.40 5.40 – 7.30 4.20 3.50 – 4.90
Agappe Diagnostics Ltd. (MISPA NANO) (4) g/dL 6.40 5.60 – 7.10 4.20 3.60 – 4.70
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) g/dL 6.80 6.05 – 7.52 4.30 3.79 – 4.86
Biuret, no serum blank, end point (3) g/dL 6.62 6.00 – 7.24 4.21 3.75 – 4.67
Biuret, serum blank, end point (3) g/dL 6.84 6.30 – 7.38 4.38 3.96 – 4.79
Fortress Diagnostics (Biuret) (BXC0173) (4) g/dL 6.53 5.55 – 7.51 4.15 3.53 – 4.77
Sekisui Medical Clinimate, Autosera, Qualigent TP (4) g/dL 6.43 6.03 – 6.83 4.05 3.65 – 4.45
Teco Diagnostics TC-Matrix (Biuret) (4) g/dL § §
SODIUM
Fortress Diagnostics (BXC0142) (4) mEq/L 253 215 – 291 183 156 – 210
ISE Indirect (3) mEq/L 144 138 – 149 126 120 – 132
Sekisui Medical Internal Standard Solution -K/-B, Dilutent -K/-B (4) mEq/L 147 137 – 157 129 119 – 139
TRANSFERRIN
TRIGLYCERIDES
Accurex Biomedical (GPO-POD) (4) mg/dL 173 127 – 219 91.4 71.4 – 111
Agappe Diagnostics Ltd. (Biolis/TMS Series) (4) mg/dL 179 161 – 198 86.1 73.7 – 98.6
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia) (4) mg/dL 170 154 – 186 82.4 72.6 – 92.2
Agappe Diagnostics Ltd. (MISPA CCXL) (4) mg/dL 170 148 – 191 82.9 72.8 – 92.9
Agappe Diagnostics Ltd. (MISPA NANO) (4) mg/dL 173 151 – 195 82.4 69.9 – 94.9
Agappe Diagnostics Ltd. (Toshiba TBA Series) (4) mg/dL 179 164 – 195 85.7 75.8 – 95.6
8
METODE (1)
Level 1 - 26461 Level 2 - 26462
TRIGLYCERIDES (terus menerus)
Enzymatic / GPO (3) mg/dL 183 160 – 206 100 83.4 – 117
Fortress Diagnostics (GPO-PAP) (BXC0271) (4) mg/dL 178 151 – 204 98.2 83.2 – 113
Sekisui Medical Cholestest, Qualigent TG (4) mg/dL 182 162 – 202 94.1 85.1 – 103
Sekisui Medical Pureauto S, Autosera S TG-N (4) mg/dL 177 162 – 192 93.4 84.4 – 102
Teco Diagnostics TC-Matrix (Enzymatic GPO Liquid) (4) mg/dL § §
UREA (5)
Accurex Biomedical (Modified Berthelot) (4) mg/dL 33.9 26.1 – 41.7 93.1 79.5 – 107
Urease (3) mg/dL 33.2 28.5 – 37.9 101 90.7 – 111
UREA NITROGEN (BUN) (5)
Accurex Biomedical (Urease, GLDH) (2) (4) mg/dL 16.0 11.8 – 20.2 43.9 34.3 – 53.5
Fortress Diagnostics (BXC0123) (4) mg/dL 12.9 11.0 – 14.8 44.6 37.9 – 51.3
Sekisui Medical Pureauto S UN (4) mg/dL 15.7 13.2 – 18.2 48.4 43.4 – 53.4
Sekisui Medical Pureauto S, Qualigent UN-L (4) mg/dL 14.7 11.7 – 17.7 45.6 40.6 – 50.6
Teco Diagnostics TC-Matrix (Urease, GLDH Liquid) (4) mg/dL § §
Urease (3) mg/dL 15.5 13.3 – 17.7 47.0 42.4 – 51.6
URIC ACID
Accurex Biomedical (Uricase) (4) mg/dL 5.45 4.59 – 6.31 9.35 7.72 – 11.0
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia - PAP) (4) mg/dL 4.67 4.10 – 5.30 9.20 8.00 – 10.4
Agappe Diagnostics Ltd. (MISPA BS 390/Clinia - TOPS) (4) mg/dL 5.15 4.40 – 5.90 8.46 7.60 – 9.30
Agappe Diagnostics Ltd. (MISPA CCXL - PAP) (4) mg/dL 4.70 4.00 – 5.40 9.30 8.10 – 10.5
Agappe Diagnostics Ltd. (MISPA CCXL - TOPS) (4) mg/dL 4.60 3.80 – 5.50 8.10 7.20 – 8.90
AUTOPAK (Enzymatic) (4) mg/dL
Fortress Diagnostics (Uricase PAP Monoliquid) (BXC0603) (4) mg/dL 4.70 3.99 – 5.40 9.04 7.69 – 10.4
Sekisui Medical Pureauto S, Autosera S, Qualigent UA (4) mg/dL 4.81 4.51 – 5.11 9.24 8.54 – 9.94
Teco Diagnostics TC-Matrix (Uricase Liquid) (4) mg/dL § §
Uricase, colorimetric (3) mg/dL 4.70 4.08 – 5.32 9.03 8.13 – 9.93
Uricase, UV (3) mg/dL 4.74 4.21 – 5.26 9.05 8.21 – 9.89
ZINC
Fortress Diagnostics (BXC0462) (4) µg/dL 104 88.4 – 120 71.8 61.0 – 82.5
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ABAXIS-PICCOLO (4)
Albumin g/dL 4.40 3.90 – 4.90 2.90 2.40 – 3.40
Alkaline Phosphatase (2) U/L 114 86.0 – 142 506 427 – 585
ALT/SGPT (2) U/L 33.0 19.0 – 47.0 97.0 81.0 – 113
Amylase (2) U/L 63.0 53.0 – 73.0 365 325 – 405
AST/SGOT (2) U/L 44.0 34.0 – 54.0 200 170 – 230
Bilirubin (Direct) mg/dL 0.300 0.100 – 0.500 1.20 0.900 – 1.50
Bilirubin (Total) mg/dL 1.10 0.700 – 1.50 4.30 3.70 – 4.90
Calcium mg/dL 9.30 8.50 – 10.1 12.0 10.8 – 13.2
Carbon Dioxide (CO2) mEq/L 35.0 27.0 – >40.0 23.0 19.0 – 27.0
Chloride mEq/L 99.0 91.0 – 107 87.0 81.0 – 93.0
Cholesterol (HDL) (7) mg/dL 65.0 56.0 – 74.0 20.0 15.0 – 25.0
Cholesterol (Total) mg/dL 241 210 – 272 108 94.0 – 122
Creatine Kinase (CK) (2) U/L 159 103 – 215 471 417 – 525
Creatinine mg/dL 1.80 1.30 – 2.30 5.20 4.40 – 6.00
Gamma Glutamyltransferase (GGT) (2) U/L 58.0 52.0 – 64.0 150 136 – 164
Glucose mg/dL 85.0 73.0 – 97.0 269 247 – 291
Lactate Dehydrogenase (LDH) (2) U/L 154 130 – 178 286 227 – 345
Magnesium mg/dL 1.90 1.60 – 2.20 4.20 3.70 – 4.70
Phosphorus mg/dL 4.00 3.40 – 4.60 8.40 7.50 – 9.30
Potassium mEq/L 3.70 3.20 – 4.20 5.80 5.20 – 6.40
Protein Serum (Total) g/dL 6.90 6.40 – 7.40 4.50 4.10 – 4.90
Sodium mEq/L 144 137 – 151 131 124 – 138
Triglycerides mg/dL 189 171 – 207 103 96.0 – 110
Urea Nitrogen (BUN) (5) mg/dL 16.0 13.0 – 19.0 47.0 42.0 – 52.0
Uric Acid mg/dL 3.70 2.90 – 4.50 8.70 7.20 – 10.2
Abbott Alinity c Analyzer
Albumin (Bromcresol green) g/dL 4.03 3.54 – 4.52 2.63 2.28 – 2.99
Alkaline Phosphatase (2) U/L 110 78.6 – 142 470 384 – 555
ALT/SGPT (IFCC) (2) U/L 27.9 23.9 – 31.8 103 96.2 – 111
Amylase ((CNP-triose/CNPG3) (IFCC) (2) U/L 85.5 69.8 – 101 498 448 – 547
AST/SGOT (2) U/L 43.4 40.4 – 46.3 216 211 – 220
Calcium (Arsenazo III) mg/dL 9.54 8.42 – 10.7 11.9 10.7 – 13.2
Chloride mEq/L 100 92.5 – 108 84.8 79.2 – 90.5
Cholesterol (HDL) mg/dL 73.7 55.7 – 91.7 31.7 21.6 – 41.9
Cholesterol (LDL) mg/dL 134 108 – 160 61.6 47.5 – 75.7
Cholinesterase (2) U/L 8812 5617 – 12006 4845 3226 – 6464
Creatinine (Alkaline picrate-kinetic, IFCC-IDMS Standardized) mg/dL 2.67 2.17 – 3.17 6.15 5.38 – 6.92
Creatinine (Enzymatic IFCC-IDMS Standardized) mg/dL 1.83 1.25 – 2.41 5.41 4.65 – 6.17
Digoxin ng/mL 1.21 0.782 – 1.63 3.20 2.86 – 3.54
Glucose mg/dL 80.4 70.3 – 90.5 280 256 – 304
Haptoglobin mg/dL 127 111 – 144 86.5 74.3 – 98.7
Iron µg/dL 229 209 – 249 68.1 58.3 – 77.9
Lactate (Lactic Acid) mg/dL 38.7 33.7 – 43.7 8.84 7.29 – 10.4
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
Abbott Alinity c Analyzer (terus menerus)
Lithium mEq/L 0.585 0.449 – 0.721 1.74 1.52 – 1.96
Magnesium mg/dL 1.88 1.59 – 2.17 4.30 3.81 – 4.80
Phosphorus mg/dL 3.25 2.81 – 3.68 7.34 6.66 – 8.01
Potassium mEq/L 3.92 3.66 – 4.18 6.26 5.90 – 6.63
Sodium mEq/L 144 137 – 151 125 119 – 131
Triglycerides mg/dL 174 150 – 197 97.3 79.6 – 115
Urea Nitrogen (BUN) mg/dL 15.1 12.8 – 17.3 46.6 41.9 – 51.4
Uric Acid mg/dL 4.77 4.10 – 5.43 9.12 8.16 – 10.1
Vancomycin µg/mL 8.89 7.10 – 10.7 38.7 33.4 – 43.9
ABBOTT ARCHITECT cSYSTEMS
Acetaminophen µg/mL 16.6 14.4 – 18.8 82.7 77.9 – 87.5
Albumin (Bromcresol Purple (BCP)) g/dL 4.01 3.64 – 4.37 2.62 2.38 – 2.86
Alkaline Phosphatase (PNPP, AMP Buffer) (2) U/L 104 82.2 – 125 442 377 – 507
ALT/SGPT (UV with P5P) (2) U/L 28.3 20.8 – 35.9 106 91.7 – 121
ALT/SGPT (UV without P5P) (2) U/L 29.0 23.1 – 35.0 102 87.5 – 116
Amylase (CNP-triose/CNPG3) (2) U/L 76.5 67.4 – 85.5 453 409 – 497
AST/SGOT (UV with P5P) (2) U/L 43.3 35.5 – 51.1 218 187 – 248
AST/SGOT (UV without P5P) (2) U/L 38.5 32.7 – 44.4 195 171 – 218
Bilirubin, Total (Diazonium Ion) (7P32) mg/dL 0.945 0.689 – 1.20 4.28 3.48 – 5.08
Bilirubin (Direct) (Diazotization) mg/dL 0.400 0.312 – 0.488 1.09 0.907 – 1.28
Bilirubin (Total) (Diazonium Ion) mg/dL 1.01 0.740 – 1.27 4.33 3.52 – 5.13
Carbamazepine (Immunoturbidimetric) (5P05-21) µg/mL 3.27 2.55 – 3.98 12.7 10.5 – 14.9
Carbon Dioxide (CO2) (Enzymatic) mEq/L 32.2 23.6 – 40.8 19.9 13.8 – 26.0
Chloride (ISE indirect) mEq/L 102 95.3 – 109 86.4 81.2 – 91.6
Cholesterol (HDL) (Ultra HDL) (7) mg/dL 73.5 62.2 – 84.8 31.8 25.1 – 38.4
Cholesterol (LDL) (Direct measure) mg/dL 134 120 – 148 61.5 53.8 – 69.2
Cholesterol (Total) (Cholesterol oxidase, esterase, peroxidase) mg/dL 257 241 – 273 104 96.1 – 112
Cholinesterase (Butyrylthiocholine (Trinder)) (Sentinel) (2) U/L 8818 8213 – 9422 4839 4427 – 5250
Complement C3 (Immunoturbidimetric) mg/dL 139 124 – 155 90.3 78.9 – 102
Creatine Kinase (CK) (NAC activated) (IFCC) (2) U/L 142 123 – 160 466 410 – 523
Creatinine (Alkaline picrate-kinetic rate blanked,IFCC-IDMS Standardized) mg/dL 2.65 2.01 – 3.29 6.09 5.45 – 6.73
Digoxin (Immunoturbidimetric) ng/mL 1.17 0.743 – 1.60 3.04 2.70 – 3.37
Gentamicin (Immunoturbidimetric) µg/mL 1.11 0.665 – 1.55 6.44 5.57 – 7.32
Glucose (Hexokinase) mg/dL 81.2 71.0 – 91.4 276 251 – 301
Glutamate Dehydrogenase (GLDH) (Dia Sys) (2) U/L § §
Haptoglobin (Immunoturbidimetric) mg/dL 125 111 – 138 86.3 76.4 – 96.2
Immunoglobulin A (IgA) (Immunoturbidimetric) mg/dL 185 149 – 222 124 99.9 – 148
Immunoglobulin G (IgG) (Immunoturbidimetric) mg/dL 951 844 – 1058 569 504 – 633
Immunoglobulin M (IgM) (Immunoturbidimetric) mg/dL 79.4 60.3 – 98.5 43.2 25.5 – 60.9
Iron (Ferene) µg/dL 225 204 – 245 68.1 59.6 – 76.5
Iron (Sentinel) µg/dL § §
Iron (UIBC) µg/dL 89.9 <41.0 – 140 142 94.3 – 190
Lactate (Lactic Acid) (Lactate to pyruvate) (9D89-21) mg/dL 39.2 32.6 – 45.7 8.90 7.18 – 10.6
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ABBOTT ARCHITECT cSYSTEMS (terus menerus)
Lactate (Lactic Acid) (Lactate to pyruvate) (9P18-21) mg/dL 39.0 32.7 – 45.4 8.80 7.12 – 10.5
Lactate Dehydrogenase (LDH) (Lactate to pyruvate) (IFCC) (2) U/L 166 136 – 197 360 317 – 402
Lipase (Enzymatic with colipase) (2) U/L 45.5 33.3 – 57.8 89.3 68.0 – 111
Lithium (Colorimetric) (Sentinel) mEq/L 0.590 0.476 – 0.704 1.69 1.46 – 1.92
Magnesium (Arsenazo I) (7D70) mg/dL 2.02 1.60 – 2.44 4.18 3.55 – 4.81
Magnesium (Enzymatic) (3P68) mg/dL 1.90 1.61 – 2.18 4.32 3.84 – 4.80
Phenobarbital (Immunoturbidimetric) (5P07-21) µg/mL 13.4 9.08 – 17.8 46.3 36.4 – 56.1
Phenytoin (EIA) (5P08-21) µg/mL 10.0 6.92 – 13.1 25.9 18.1 – 33.7
Phosphorus (Phosphomolybdate method) mg/dL 3.23 2.91 – 3.55 7.25 6.75 – 7.75
Potassium (ISE indirect) mEq/L 3.89 3.63 – 4.15 6.22 5.84 – 6.60
Protein Serum (Total) (Biuret, no serum blank, end point) g/dL 6.67 6.23 – 7.11 4.09 3.71 – 4.47
Salicylate (Enzymatic) mg/dL <5.00 – 6.92 13.2 11.2 – 15.1
Sodium (ISE indirect) mEq/L 144 137 – 150 125 119 – 131
Theophylline (EIA) (5P06-21) µg/mL 9.22 7.54 – 10.9 27.5 24.6 – 30.5
Tobramycin (Immunoturbidimetric) µg/mL 9.67 7.88 – >10.0 2.49 1.74 – 3.25
Transferrin (Immunoturbidimetric) mg/dL 252 223 – 281 168 149 – 187
Triglycerides (Enzymatic, end point) mg/dL 179 165 – 194 102 91.9 – 112
Urea Nitrogen (BUN) (Urease, UV) (5) mg/dL 15.3 13.6 – 16.9 47.9 43.3 – 52.4
Uric Acid (Uricase, colorimetric) mg/dL 4.74 4.20 – 5.28 9.22 8.27 – 10.2
Valproic Acid (Immunoturbidimetric) µg/mL 34.1 29.5 – 38.7 126 114 – 137
Vancomycin (Immunoturbidimetric) µg/mL 8.06 6.37 – 9.76 33.5 28.5 – 38.5
BECKMAN COULTER ACCESS / 2 / 2i
Cortisol µg/dL 9.65 7.97 – 11.3 39.5 34.0 – 45.0
hCG (Total BhCG) (5th IS) mIU/mL 85.8 75.3 – 96.4 102 75.3 – 128
BECKMAN COULTER AU SYSTEMS
Acetaminophen (Emit 2000) µg/mL 17.5 14.7 – 20.3 78.1 67.3 – 88.9
Alkaline Phosphatase (PNPP, AMP Buffer) (IFCC 2002) (Europe/Asia) (2) U/L 132 88.1 – 176 570 390 – 750
ALT/SGPT (UV with P5P) (Europe/Asia) (2) U/L 29.8 22.1 – 37.5 104 85.4 – 122
ALT/SGPT (UV without P5P) (2) U/L 26.5 18.9 – 34.1 91.7 69.3 – 114
Amylase (G7 PNP, Blocked) (Europe/Asia) (2) U/L 82.3 61.5 – 103 424 350 – 497
AST/SGOT (UV with P5P) (IFCC 2002)(Europe/Asia) (2) U/L 42.9 33.4 – 52.4 222 191 – 252
Bilirubin (Direct) (Diazotization) (Europe/Asia) mg/dL 0.298 0.198 – 0.398 1.42 1.15 – 1.68
Bilirubin (Total) (DPD) mg/dL 1.00 0.815 – 1.18 4.29 3.66 – 4.93
Bilirubin (Total) (DPD) (Europe/Asia) mg/dL 1.05 0.867 – 1.24 4.32 3.68 – 4.96
Carbamazepine (EIA) (Emit 2000) µg/mL 3.07 2.09 – 4.05 15.5 10.9 – 20.0
Carbon Dioxide (CO2) (Enzymatic) mEq/L 37.3 28.0 – >45.0 21.2 14.7 – 27.7
Cholesterol (HDL) (Direct measure, immunoinhibition) (Europe/Asia) (7) mg/dL 66.8 53.8 – 79.7 26.6 20.3 – 32.9
Cholesterol (HDL) (Direct measure, polymer-polyanion) (7) mg/dL 79.1 57.3 – 101 32.1 23.1 – 41.2
Cholesterol (LDL) (OSR6X83) (Europe/Asia) mg/dL 147 93.3 – 201 68.7 43.8 – 93.6
Cholesterol (LDL) (OSR6X96) mg/dL 123 76.7 – 168 57.4 36.8 – 78.0
Cholesterol (Total) (Cholesterol oxidase, esterase, peroxidase) mg/dL 247 220 – 275 99.6 86.7 – 112
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
BECKMAN COULTER AU SYSTEMS (terus menerus)
Cholesterol (Total) (Cholesterol oxidase, esterase, peroxidase) (Europe/Asia) mg/dL 260 231 – 288 105 91.1 – 118
Cholinesterase (Butyrylthiocholine (Trinder)) (Europe/Asia) (2) U/L 7146 5877 – 8415 3940 3278 – 4601
Creatine Kinase (CK) (NAC activated) (2) U/L 125 92.7 – 158 415 318 – 511
Creatine Kinase (CK) (NAC activated) (Europe/Asia) (2) U/L 144 108 – 181 481 370 – 593
Creatinine (Alkaline picrate-kinetic) (Europe/Asia) mg/dL 2.01 1.67 – 2.34 5.28 4.84 – 5.72
Digoxin (EIA) (Emit 2000) ng/mL 1.58 1.01 – 2.16 3.61 2.72 – 4.50
Gamma Glutamyltransferase (GGT) (2) U/L 51.8 35.6 – 68.0 133 94.3 – 171
Gamma Glutamyltransferase (GGT) (IFCC 2002)(Europe/Asia) (2) U/L 61.0 43.5 – 78.5 158 112 – 204
Gentamicin (EIA) (Emit 2000) µg/mL 1.36 0.900 – 1.83 6.82 5.90 – 7.74
Glutamate Dehydrogenase (GLDH) (Dia Sys) (2) U/L 6.65 5.01 – 8.29 13.3 11.5 – 15.1
Immunoglobulin A (IgA) (Immunoturbidimetric) mg/dL 191 156 – 226 129 105 – 152
Iron (TPTZ-no deproteinization) µg/dL 258 227 – 290 74.9 63.8 – 86.1
Iron (TPTZ-no deproteinization) (Europe/Asia) µg/dL 237 208 – 265 68.4 58.0 – 78.7
Iron (UIBC) (Nitroso-PSAP) µg/dL 102 75.5 – 128 151 125 – 177
Lactate (Lactic Acid) (Lactate to pyruvate) (OSR6193) (Europe/Asia) mg/dL 38.1 30.8 – 45.5 8.81 7.27 – 10.4
Lactate Dehydrogenase (LDH) (IFCC 2002)(Europe/Asia) (2) U/L 175 133 – 218 384 293 – 476
Lactate Dehydrogenase (LDH) (Lactate to pyruvate) (2) U/L 145 110 – 180 312 237 – 386
Lipase (Enzymatic, colorimetric) (2) U/L 43.5 26.4 – 60.6 85.2 47.1 – 123
Lithium (Colorimetric) mEq/L 0.580 0.509 – 0.651 1.62 1.44 – 1.80
Lithium (Photometric, end point) (Europe/Asia) mEq/L 0.536 0.421 – 0.651 1.61 1.38 – 1.84
Magnesium (Xylidyl blue) mg/dL 2.03 1.74 – 2.31 4.31 3.74 – 4.89
Phenobarbital (EIA) (Emit 2000) µg/mL 12.2 6.23 – 18.1 43.8 32.0 – 55.6
Phenytoin (EIA) (Emit 2000) µg/mL 9.60 6.63 – 12.6 25.1 17.6 – 32.6
Protein Serum (Total) (Biuret, reagent blank, end point) g/dL 6.55 5.92 – 7.18 4.18 3.72 – 4.64
Salicylate (EIA) mg/dL 7.02 6.26 – 7.78 15.7 11.9 – 19.5
Theophylline (EIA) (Emit 2000) µg/mL 8.84 7.07 – 10.6 27.1 21.9 – 32.3
Tobramycin (EIA) (Emit 2000) µg/mL 7.24 6.02 – 8.47 1.62 1.15 – 2.10
Triglycerides (Enzymatic, end point) mg/dL 180 156 – 205 94.8 79.9 – 110
Triglycerides (Enzymatic, end point) (Europe/Asia) mg/dL 179 155 – 203 95.0 80.2 – 110
Uric Acid (Uricase, colorimetric) (Europe/Asia) mg/dL 4.78 4.30 – 5.26 9.54 8.36 – 10.7
Valproic Acid (EIA) (Emit 2000) µg/mL 40.3 23.3 – 57.2 129 94.0 – >150
Vancomycin (EIA) (Emit 2000) µg/mL 6.45 5.09 – 7.82 26.6 22.6 – 30.7
BECKMAN COULTER SYNCRON/UniCel DxC SERIES
Acetaminophen (Immunoturbidimetric) µg/mL 26.7 19.9 – 33.5 98.6 82.6 – 114
ALT/SGPT (UV with P5P) (IFCC 2002) (2) U/L § §
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
BECKMAN COULTER SYNCRON/UniCel DxC SERIES (terus menerus)
Amylase (G7 PNP, Blocked) (2) U/L 79.6 69.1 – 90.0 430 391 – 470
AST/SGOT (UV with P5P) (IFCC 2002) (2) U/L § §
Bilirubin (Direct) (Diazotization) mg/dL 0.209 <0.100 – 0.337 0.856 0.696 – 1.02
Bilirubin (Total) (Jendrassik Grof) mg/dL 1.21 0.812 – 1.62 4.60 3.99 – 5.22
Calcium (ISE indirect) mg/dL 9.40 8.79 – 10.0 11.9 11.1 – 12.6
Carbamazepine (Immunoturbidimetric) µg/mL 2.76 2.23 – 3.29 14.5 12.3 – 16.7
Carbon Dioxide (CO2) (ISE indirect) mEq/L 32.9 26.7 – 39.1 19.1 14.8 – 23.4
Cholesterol (HDL) (Direct measure, polymer-polyanion) (HDL)(REF A15625) (7) mg/dL 78.2 62.1 – 94.2 31.1 23.0 – 39.1
Cholinesterase (Butyrylthiocholine (Trinder)) (CHEX) (2) kU/L 7.52 6.85 – 8.18 4.23 3.75 – 4.72
Creatine Kinase (CK) (NAC activated) (2) U/L 151 123 – 178 495 427 – 564
Creatine Kinase (CK) (Rosalki, other modified) (2) U/L 141 121 – 161 464 396 – 533
Digoxin (Immunoturbidimetric) ng/mL 1.23 0.770 – 1.69 3.04 2.58 – 3.50
Gamma Glutamyltransferase (GGT) (IFCC 2002) (2) IU/L § §
Gamma Glutamyltransferase (GGT) (Szasz) (2) U/L 57.2 44.8 – 69.6 162 135 – 189
Glucose (Glucose oxidase, oxygen consumption) (GLUCm) mg/dL
Glucose (Hexokinase) (GLUH) mg/dL 83.9 71.3 – 96.5 279 252 – 306
Iron (Ferrozine-no deproteinization) µg/dL 235 211 – 259 68.7 59.7 – 77.7
Iron (TIBC) (Ion exchange resin, ferrozine) µg/dL 340 299 – 381 222 195 – 248
Lactate (Lactic Acid) (Enzymatic) mg/dL 36.4 32.1 – 40.6 9.33 7.40 – 11.3
Lactate Dehydrogenase (LDH) (IFCC) (2) U/L § §
Lipase (Colorimetric) (2) U/L 43.7 30.3 – 57.0 78.3 58.6 – 98.0
Magnesium (Calmagite) mg/dL 1.99 1.69 – 2.29 4.15 3.62 – 4.67
Phenobarbital (Immunoturbidimetric) µg/mL 13.9 9.46 – 18.3 46.6 36.6 – 56.6
Phenytoin (Immunoturbidimetric) µg/mL 10.7 9.32 – 12.1 24.4 20.5 – 28.4
Phosphorus (Phosphomolybdate method) (PHOSm) mg/dL 3.48 2.88 – 4.08 7.77 6.73 – 8.81
Phosphorus (Phosphomolybdate method) (PHS) mg/dL 3.34 2.76 – 3.93 7.54 6.53 – 8.56
Protein Serum (Total) (Biuret, kinetic) (TPm) g/dL 6.32 5.79 – 6.85 4.04 3.64 – 4.44
Protein Serum (Total) (Biuret, no serum blank, end point) (TP) g/dL 6.73 5.96 – 7.50 4.37 3.84 – 4.89
Salicylate (Enzymatic) mg/dL 5.58 <4.00 – 7.50 15.5 13.9 – 17.1
Theophylline (Immunoturbidimetric) µg/mL 8.14 6.45 – 9.84 24.1 21.0 – 27.2
Tobramycin (Immunoturbidimetric) µg/mL 8.79 7.08 – 10.5 2.12 1.43 – 2.80
Triglycerides (Enzymatic with glycerol blank) mg/dL 192 166 – 218 97.4 81.8 – 113
Urea Nitrogen (BUN) (Conductivity (Conductometry)) (BUNm) (5) mg/dL 15.0 11.5 – 18.5 45.9 40.1 – 51.7
Urea Nitrogen (BUN) (Urease, UV) (BUN) (5) mg/dL 16.6 14.1 – 19.1 48.7 43.2 – 54.3
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
BECKMAN COULTER SYNCRON/UniCel DxC SERIES (terus menerus)
Valproic Acid (Immunoturbidimetric) µg/mL 37.8 25.5 – 50.0 120 97.4 – 143
Vancomycin (Immunoturbidimetric) µg/mL 8.16 6.45 – 9.86 32.9 28.0 – 37.8
BIOSYSTEMS B400/A25/A15 (4)
Albumin g/dL 4.45 3.65 – 5.25 2.86 2.35 – 3.37
Alkaline Phosphatase (PNPP, DEA Buffer) (2) U/L 162 133 – 191 566 464 – 668
Amylase (Pancreatic) (G7 PNP immunoinhibition) (2) U/L 43.2 35.4 – 51.0 369 303 – 435
Calcium (o-cresolphthalein complexone) mg/dL 9.48 8.34 – 10.6 12.4 10.9 – 13.9
Cholesterol (LDL) mg/dL 127 95.3 – 159 58.3 43.7 – 72.9
Creatinine (Alkaline picrate-kinetic) mg/dL 2.20 1.80 – 2.60 5.14 4.21 – 6.07
Gamma Glutamyltransferase (GGT) (IFCC) (2) U/L 61.8 50.7 – 72.9 163 134 – 192
Glucose mg/dL 83.6 71.1 – 96.1 272 231 – 313
Iron (Ferrozine) µg/dL 196 162 – 230 64.3 53.0 – 75.6
Lactate Dehydrogenase (LDH) (IFCC) (2) U/L 179 147 – 211 379 311 – 447
Lactate Dehydrogenase (LDH) (Pyruvate to lactate) (2) U/L 358 294 – 422 807 662 – 952
Magnesium (Xylidyl blue) mg/dL 2.07 1.66 – 2.48 >4.00
Protein Serum (Total) (Biuret) g/dL 6.70 5.90 – 7.50 4.27 3.76 – 4.78
Triglycerides (Glycerol phosphate oxydase/peroxydase) mg/dL 175 149 – 201 91.2 77.5 – 105
Urea (Urease, UV) (5) mg/dL 30.7 26.1 – 35.3 92.2 78.4 – 106
ELITECH SELECTRA SYSTEMS (Q-Line) (4)
Albumin g/dL § §
Alkaline Phosphatase (SL) (2) U/L § §
ALT/SGPT (SL) (2) U/L § §
Amylase (SL) (2) U/L § §
AST/SGOT (SL) (2) U/L § §
Bilirubin (Direct) mg/dL § §
Bilirubin (Total) mg/dL § §
Calcium (Arsenazo III) mg/dL § §
Chloride mEq/L § §
Cholesterol (HDL) (Direct) (7) mg/dL § §
Cholesterol (LDL) (Direct) mg/dL § §
Cholesterol (Total) (SL) mg/dL § §
Creatinine (Jaffe) mg/dL § §
Creatinine (SL) mg/dL § §
Gamma Glutamyltransferase (GGT) (Plus) (SL) (2) U/L § §
Glucose (PAP) (SL) mg/dL § §
Lactate Dehydrogenase (LDH) (LDH-P) (SL) (2) U/L § §
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ELITECH SELECTRA SYSTEMS (Q-Line) (4) (terus menerus)
Lipase (SL) (2) U/L § §
Magnesium mg/dL § §
Phosphorus mg/dL § §
Protein Serum (Total) g/dL § §
Triglycerides (Mono) (SL) mg/dL § §
Urea (5) mg/dL § §
Uric Acid mg/dL § §
ERBA XL SERIES (4)
Albumin g/dL 4.06 3.46 – 4.66 2.88 2.46 – 3.30
Albumin (India Market Only) g/dL 4.13 3.50 – 4.76 2.89 2.47 – 3.31
Alkaline Phosphatase (IFCC Optimized) (2) U/L 121 97.0 – 145 516 414 – 618
Alkaline Phosphatase (India Market Only) (2) U/L 125 101 – 149 524 419 – 629
ALT/SGPT (2) U/L 27.7 22.3 – 33.1 98.0 78.5 – 118
ALT/SGPT (Modified IFCC) (India Market Only) (2) U/L 28.0 22.3 – 33.7 99.5 79.7 – 119
Amylase (2) U/L 57.7 46.3 – 69.1 408 327 – 489
AST/SGOT (2) U/L 38.6 30.8 – 46.4 206 164 – 248
AST/SGOT (Modified IFCC) (India Market Only) (2) U/L 38.1 30.6 – 45.6 203 161 – 245
Bilirubin (Direct) (DCA) mg/dL 0.400 0.310 – 0.490 1.18 0.880 – 1.48
Bilirubin (Total) (DCA) mg/dL 0.910 0.670 – 1.15 4.42 3.31 – 5.53
Calcium mg/dL 9.54 8.10 – 11.0 12.5 10.7 – 14.3
Calcium (India Market Only) mg/dL 9.49 8.08 – 10.9 12.1 10.3 – 13.9
Chloride mEq/L 103 92.0 – 114 86.4 77.7 – 95.1
Chloride (Mercuric Thiocyanate) mEq/L 105 90.0 – 120 102 87.0 – 117
Cholesterol (LDL) mg/dL 148 118 – 178 63.8 50.9 – 76.7
Creatinine (Alkaline picrate-kinetic) mg/dL 2.56 2.05 – 3.07 5.57 4.46 – 6.68
Creatinine (Enzymatic) mg/dL 1.85 1.49 – 2.21 5.48 4.37 – 6.59
Creatinine (Enzymatic) (India Market Only) mg/dL 1.78 1.42 – 2.14 5.40 4.20 – 6.60
Glucose mg/dL 89.1 75.6 – 103 292 247 – 337
Glucose (Hexokinase) (India Market Only) mg/dL
Iron µg/dL 212 170 – 254 59.9 47.9 – 71.9
Iron (UIBC) µg/dL 83.7 66.9 – 101 129 102 – 156
Lipase (2) U/L 44.3 35.3 – 53.3 65.2 52.3 – 78.1
Lithium mEq/L 0.540 0.480 – 0.600 1.66 1.48 – 1.84
Magnesium mg/dL 1.93 1.63 – 2.23 3.98 3.38 – 4.58
Phosphorus (India Market Only) mg/dL 3.59 3.05 – 4.13 7.00 5.80 – 8.20
Phosphorus (New Formulation) mg/dL 3.65 3.11 – 4.19 7.43 6.32 – 8.54
Potassium mEq/L 3.79 3.40 – 4.18 5.94 5.34 – 6.54
Protein Serum (Total) (India Market Only) g/dL
Sodium mEq/L 146 131 – 161 126 114 – 138
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ERBA XL SERIES (4) (terus menerus)
Triglycerides mg/dL 184 157 – 211 107 91.0 – 124
Triglycerides (India Market Only) mg/dL 162 138 – 186 81.5 69.2 – 93.8
Urea (5) mg/dL 34.8 29.7 – 39.9 106 91.0 – 121
Uric Acid mg/dL 5.45 4.64 – 6.26 10.2 8.70 – 11.7
Uric Acid (Single Reagent) mg/dL 6.43 5.47 – 7.39 9.60 8.10 – 11.1
FUJI DRI-CHEM Series (4)
Albumin g/dL 6.00 5.60 – >6.00 4.30 3.70 – 4.90
Alkaline Phosphatase (ALP-PIII) (IFCC) (2) U/L 54.0 43.0 – 65.0 294 255 – 333
Alkaline Phosphatase (ALP-PIII) (JSCC) (2) U/L 168 136 – 201 877 761 – 992
ALT/SGPT (2) U/L 23.0 16.0 – 29.0 84.0 74.0 – 94.0
Amylase (2) U/L 83.0 71.0 – 96.0 359 319 – 400
AST/SGOT (2) U/L 38.0 31.0 – 44.0 208 186 – 230
Bilirubin (Direct) mg/dL 0.100 <0.100 – 0.300 1.20 1.00 – 1.40
Calcium mg/dL 9.60 8.30 – 11.0 12.9 11.3 – 14.4
Carbon Dioxide (CO2) mEq/L 34.8 26.0 – >40.0 20.7 14.0 – 28.0
Chloride mEq/L 96.0 90.0 – 103 86.0 80.0 – 92.0
Creatinine mg/dL 1.50 1.00 – 1.90 4.90 4.30 – 5.40
Glucose mg/dL 68.0 59.0 – 78.0 242 219 – 265
LAP Arylamidase (2) U/L 26.0 11.0 – 41.0 29.0 14.0 – 44.0
Lipase (2) U/L 46.0 30.0 – 62.0 89.0 73.0 – 105
Magnesium mg/dL 3.30 2.90 – 3.80 5.50 4.80 – 6.10
Phosphorus mg/dL 3.20 2.70 – 3.70 8.00 7.00 – 9.00
Potassium mEq/L 4.00 3.60 – 4.40 6.20 5.70 – 6.70
Sodium mEq/L 148 142 – 154 129 124 – 135
Triglycerides mg/dL 132 112 – 151 74.0 59.0 – 88.0
Urea Nitrogen (BUN) (5) mg/dL 15.9 13.9 – 17.8 46.6 42.2 – 51.0
Uric Acid mg/dL 4.30 3.80 – 4.90 9.20 8.30 – 10.1
ORTHO VITROS MICROSLIDE SERIES
Acetaminophen (Enzymatic, colorimetric) µg/mL 14.6 12.5 – 16.7 85.8 77.6 – 94.1
Alkaline Phosphatase (PNPP, AMP Buffer-VITROS) (2) U/L 62.4 46.6 – 78.2 270 218 – 322
ALT/SGPT (2) U/L § §
ALT/SGPT (ALTv) (2) U/L 26.1 22.4 – 29.8 86.9 80.0 – 93.7
Amylase (Amylopectin, colorimetric-VITROS) (2) U/L 69.4 50.3 – 88.6 237 184 – 289
AST/SGOT (Enzymatic, colorimetric-VITROS) (2) U/L 49.0 40.7 – 57.3 229 199 – 258
Bilirubin (Direct) (Spectrophotometric) mg/dL § §
Bilirubin (Indirect) (Direct measure) mg/dL 0.544 0.110 – 0.978 3.64 2.82 – 4.46
Bilirubin (Total) (Diphylline, Diazonium Salt-VITROS) (TBIL) mg/dL 0.798 0.359 – 1.24 4.26 3.27 – 5.25
Carbamazepine (EIA) µg/mL <3.00 – 3.38 14.0 9.61 – 18.5
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ORTHO VITROS MICROSLIDE SERIES (terus menerus)
Chloride (ISE direct) mEq/L 102 94.2 – 110 86.5 79.7 – 93.4
Cholesterol (HDL) (Direct measure, PTA/MgCl2-VITROS) (7) mg/dL 66.7 53.4 – 80.1 26.0 20.9 – 31.1
Cholesterol (LDL) (Calculated) mg/dL 138 87.8 – 189 57.2 33.6 – 80.9
Creatine Kinase (CK) (Rosalki, other modified-VITROS) (2) U/L 75.7 55.8 – 95.6 322 246 – 398
Creatinine (Enzymatic-VITROS, IFCC-IDMS Standardized) mg/dL 1.87 1.59 – 2.16 5.51 4.82 – 6.21
Digoxin (EIA) ng/mL 1.01 <0.400 – 1.62 3.16 2.29 – >4.00
Glucose (Glucose oxidase, hydrogen peroxide (Trinder)) mg/dL 90.3 80.3 – 100 270 245 – 294
Iron (Pyridyl azo dye) µg/dL 275 220 – 330 73.2 49.7 – 96.6
Lactate (Lactic Acid) (Lactate to pyruvate) mg/dL 39.6 36.1 – 43.1 8.56 6.56 – 10.6
Lactate Dehydrogenase (LDH) (Pyruvate to lactate-VITROS) (2) U/L 449 353 – 544 1068 937 – 1198
Lipase (Enzymatic with colipase-VITROS) (2) U/L 386 320 – 453 1087 901 – 1274
Lithium (Colorimetric) mEq/L 0.244 <0.200 – 0.371 1.25 1.01 – 1.48
Magnesium (Formazan dye) mg/dL 1.79 1.47 – 2.10 4.47 3.88 – 5.06
Phenytoin (EIA) µg/mL 9.51 6.44 – 12.6 25.6 17.4 – 33.9
Phosphorus (Phosphomolybdate reduction-VITROS) mg/dL 3.24 2.76 – 3.72 6.96 6.00 – 7.93
Potassium (ISE direct) mEq/L 4.00 3.70 – 4.31 6.34 5.89 – 6.78
Protein Serum (Total) (Biuret, no serum blank, end point-VITROS) g/dL 5.30 4.58 – 6.02 3.67 3.16 – 4.19
Salicylate (Colorimetric-VITROS) mg/dL 6.35 4.74 – 7.96 15.5 12.7 – 18.4
Sodium (ISE direct) mEq/L 147 136 – 157 131 122 – 140
Theophylline (Enzymetric) µg/mL 35.5 24.2 – >40.0 >40.0
Urea Nitrogen (BUN) (Urease, colorimetric) (5) mg/dL 15.7 13.5 – 17.9 42.6 37.9 – 47.3
ORTHO VITROS MICROTIP SERIES
Iron (TIBC) (Chromazurol B-VITROS) µg/dL 325 310 – 340 250 239 – 261
Tobramycin (EIA) µg/mL § §
Valproic Acid (EIA) µg/mL 38.7 21.7 – 55.8 124 89.9 – >150
Vancomycin (EIA) µg/mL 7.47 5.95 – 9.00 29.9 25.4 – 34.4
ROCHE / HITACHI COBAS C SYSTEMS
Acetaminophen (EIA) (ACET2) (REF 06769942190) µg/mL 17.8 15.1 – 20.5 78.6 73.3 – 83.8
Acetaminophen (Enzymatic, colorimetric) (REF 20767174160) µg/mL § §
Acetaminophen (Enzymatic, colorimetric) (REF 20767174322) µg/mL § §
Alkaline Phosphatase (ALP2 (IFCC Schumann calibration)) (2) U/L 93.4 82.7 – 104 381 348 – 413
Alkaline Phosphatase (PNPP, AMP Buffer) (2) U/L 96.6 81.5 – 112 395 349 – 442
ALT/SGPT (UV with P5P) (IFCC 2002) (2) U/L 29.4 25.0 – 33.8 101 87.8 – 115
ALT/SGPT (UV without P5P) (2) U/L 27.6 22.3 – 32.9 98.3 86.0 – 111
Amylase (Pancreatic) (G7 PNP immunoinhibition) (2) U/L 43.1 39.0 – 47.3 359 339 – 379
AST/SGOT (UV with P5P) (IFCC 2002) (2) U/L 41.0 32.4 – 49.7 214 177 – 251
Bilirubin (Direct) (Diazotization) (BILD2) mg/dL 0.395 0.308 – 0.482 1.43 1.20 – 1.66
Bilirubin (Direct) (Diazotization) (DBILI) mg/dL 0.221 <0.200 – 0.273 0.965 0.808 – 1.12
Bilirubin (Total) (Diazonium Ion, Blanked (Roche)) (BILT3) mg/dL 0.854 0.681 – 1.03 4.01 3.47 – 4.55
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ROCHE / HITACHI COBAS C SYSTEMS (terus menerus)
Bilirubin (Total) (Diazonium Ion, Blanked (Roche)) (BILTS) mg/dL 0.874 0.704 – 1.04 4.06 3.53 – 4.60
Calcium (BAPTA) (CA2) mg/dL 9.31 8.73 – 9.89 11.9 11.3 – 12.6
Carbamazepine (EIA) µg/mL 2.77 2.25 – 3.28 14.5 12.3 – 16.7
Cholesterol (HDL) (Direct measure, polymer-polyanion) (HDLC4) (7) mg/dL 59.9 54.4 – 65.5 24.5 22.1 – 26.9
Cholesterol (HDL) (Direct measure-PEG) (7) mg/dL 60.1 51.7 – 68.5 24.6 21.3 – 27.8
Cholesterol (LDL) (Direct measure) mg/dL § §
Cholesterol (LDL) (Direct measure) (LDLC3) mg/dL 140 107 – 172 62.6 50.4 – 74.8
Cholinesterase (Butyrylthiocholine (Trinder)) (2) U/L 7268 6683 – 7854 4051 3686 – 4415
Cortisol (Electrochemiluminescence (ECL)) µg/dL 11.9 10.5 – 13.2 40.3 32.8 – 47.8
Creatine Kinase (CK) (NAC activated) (IFCC 2002) (2) U/L 136 121 – 151 428 388 – 469
Creatine Kinase (CK) (NAC activated) (IFCC 2002) (Cobas 8000) (2) U/L 136 122 – 151 429 390 – 469
Creatinine (Alkaline picrate-kinetic rate blanked,IFCC-IDMS Standardized) mg/dL 1.94 1.64 – 2.25 5.26 4.63 – 5.89
Creatinine (Enzymatic IFCC-IDMS Standardized) mg/dL 1.84 1.67 – 2.00 5.34 4.95 – 5.72
Digoxin (KIMS (Roche)) ng/mL 1.30 0.904 – 1.69 3.35 2.93 – 3.76
Gamma Glutamyltransferase (GGT) (IFCC 2002) (2) U/L 60.5 48.1 – 73.0 158 126 – 190
Haptoglobin (Immunoturbidimetric) mg/dL 123 107 – 139 84.3 72.7 – 95.9
Iron (Ferrozine-no deproteinization) µg/dL 228 212 – 245 68.4 59.4 – 77.4
Iron (TIBC) (Calculated) µg/dL 309 261 – 356 203 165 – 240
Iron (UIBC) (Ferrozine) µg/dL 84.6 53.7 – 116 137 101 – 174
Lipase (Enzymatic, colorimetric) (2) U/L 42.3 35.9 – 48.8 64.2 54.3 – 74.0
Magnesium (Chlorophosphonazo III) mg/dL 2.03 1.76 – 2.29 4.35 3.94 – 4.76
Magnesium (Xylidyl blue) (MG2) mg/dL 2.02 1.80 – 2.24 4.32 3.98 – 4.65
Phenobarbital (KIMS (Roche)) µg/mL 12.1 10.6 – 13.6 44.8 42.7 – 47.0
Phenytoin (KIMS (Roche)) µg/mL 9.63 6.55 – 12.7 24.9 16.7 – 33.0
Protein Serum (Total) (Biuret, serum blank, end point) g/dL 6.62 6.14 – 7.10 4.19 3.87 – 4.52
Salicylate (Enzymatic) mg/dL 5.89 3.98 – 7.80 13.5 11.8 – 15.2
Theophylline (KIMS (Roche)) µg/mL 8.12 7.28 – 8.96 24.5 22.7 – 26.3
Valproic Acid (EIA) µg/mL 36.0 26.6 – 45.3 116 89.9 – 142
Vancomycin (EIA) µg/mL 7.84 6.24 – 9.43 30.0 25.4 – 34.6
Vancomycin (KIMS (Roche)) (VANC3) µg/mL 7.36 5.20 – 9.52 29.9 27.1 – 32.6
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ROCHE COBAS INTEGRA
Acetaminophen (EIA) (ACET2) µg/mL 17.0 14.7 – 19.2 75.7 56.8 – 94.5
ALT/SGPT (UV with P5P) (IFCC 2002) (2) U/L 26.0 19.3 – 32.7 98.4 83.3 – 114
AST/SGOT (UV with P5P) (2) U/L 40.3 33.3 – 47.2 218 193 – 242
AST/SGOT (UV without P5P) (2) U/L § §
Bilirubin (Direct) (Jendrassik Grof) (BILD2) mg/dL 0.397 0.283 – 0.512 1.26 1.02 – 1.51
Bilirubin (Total) (Diazonium Ion, Blanked (Roche)) (BILT3) mg/dL 0.802 0.608 – 0.995 3.77 3.18 – 4.35
Bilirubin (Total) (Diazonium Ion, Blanked (Roche)) (BILTS) mg/dL § §
Calcium (BAPTA) (CA2) mg/dL 9.16 8.56 – 9.76 11.9 11.2 – 12.5
Carbamazepine (Fluorescence Polarization-Roche) µg/mL 2.69 2.32 – 3.06 15.8 12.8 – 18.8
Carbon Dioxide (CO2) (Enzymatic) mEq/L § §
Cholesterol (HDL) (Direct measure-PEG) (7) mg/dL § §
Cholesterol (LDL) (Direct measure) mg/dL § §
Cholesterol (Total) (Cholesterol oxidase, esterase, peroxidase) mg/dL 241 219 – 264 98.5 89.1 – 108
Cholinesterase (Butyrylthiocholine (Trinder)) (2) U/L § §
Complement C3 (Immunoturbidimetric) mg/dL § §
Creatine Kinase (CK) (NAC activated) (2) U/L 132 112 – 153 423 363 – 483
Creatinine (Alkaline picrate-kinetic, IFCC-IDMS Standardized) (CREJ2) mg/dL 1.93 1.62 – 2.23 5.11 4.48 – 5.73
Creatinine (Enzymatic IFCC-IDMS Standardized) (CREP2) mg/dL § §
Digoxin (KIMS (Roche)) ng/mL § §
Gentamicin (Fluorescence Polarization-Roche) µg/mL 1.44 1.34 – 1.54 7.29 6.51 – 8.08
Haptoglobin (Immunoturbidimetric) mg/dL § §
Immunoglobulin A (IgA) (Immunoturbidimetric) mg/dL § §
Immunoglobulin G (IgG) (Immunoturbidimetric) mg/dL § §
Immunoglobulin M (IgM) (Immunoturbidimetric) mg/dL § §
Iron (Ferrozine-no deproteinization) µg/dL § §
Lactate Dehydrogenase (LDH) (Lactate to pyruvate) (2) U/L § §
Lactate Dehydrogenase (LDH) (Lactate to pyruvate) (IFCC 2002) (2) U/L 179 161 – 198 388 350 – 426
Lipase (Enzymatic, colorimetric) (2) U/L 46.0 37.7 – 54.4 74.9 61.7 – 88.1
Lithium (ISE direct) mEq/L 0.541 0.438 – 0.644 1.66 1.43 – 1.88
Magnesium (Chlorophosphonazo III) mg/dL 2.06 1.67 – 2.46 4.32 3.69 – 4.95
Phenobarbital (Fluorescence Polarization-Roche) µg/mL 12.4 9.97 – 14.8 43.4 37.1 – 49.8
Phenytoin (Fluorescence Polarization-Roche) µg/mL 10.2 8.50 – 11.9 23.7 19.3 – 28.2
Protein Serum (Total) (Biuret, serum blank, end point) g/dL 6.15 5.55 – 6.76 3.91 3.44 – 4.37
Salicylate (Enzymatic) mg/dL § §
Theophylline (Fluorescence Polarization-Roche) µg/mL § §
Tobramycin (Fluorescence Polarization-Roche) µg/mL § §
Transferrin (Immunoturbidimetric) mg/dL § §
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
ROCHE COBAS INTEGRA (terus menerus)
Valproic Acid (Fluorescence Polarization-Roche) µg/mL 34.7 30.1 – 39.2 117 99.4 – 135
Vancomycin (Fluorescence Polarization-Roche) µg/mL § §
SIEMENS ADVIA CENTAUR CP
Carbamazepine (CARB) µg/mL 2.77 2.12 – 3.43 14.3 11.9 – 16.7
Cortisol (COR) µg/dL 11.1 10.6 – 11.7 41.9 37.0 – 46.9
Digoxin (DIG) ng/mL 1.22 0.800 – 1.64 3.43 2.84 – 4.02
Gentamicin (GENT) µg/mL 1.25 0.796 – 1.71 6.93 5.99 – 7.86
Phenobarbital (PHNB) µg/mL 14.1 9.27 – 19.0 52.4 40.9 – 63.9
Phenytoin (PHTN) µg/mL 10.8 8.28 – 13.3 27.7 21.6 – 33.8
T3 (Total) (T3) ng/mL 0.749 0.701 – 0.796 4.16 3.77 – 4.55
T3 Uptake/T Uptake (TUp) T Uptake Unit 0.976 0.925 – 1.03 1.93 1.86 – 2.01
T4 (Free) (FT4) ng/dL 1.27 1.20 – 1.35 7.12 6.57 – 7.67
T4 (Total) (T4) µg/dL 6.52 5.00 – 8.04 23.6 18.4 – 28.9
Theophylline (THEO2) µg/mL 8.69 7.09 – 10.3 23.5 17.4 – 29.6
Thyroid Stimulating Hormone (TSH) (TSH) µIU/mL 1.93 1.26 – 2.60 21.7 18.0 – 25.4
Thyroid Stimulating Hormone (TSH) (TSH3UL) µIU/mL 1.28 0.759 – 1.80 13.9 10.5 – 17.2
Valproic Acid (VALP) µg/mL 37.4 29.0 – 45.7 124 103 – 145
Vancomycin (VANC) µg/mL 4.81 3.41 – 6.21 23.5 19.9 – 27.1
Vitamin B12 (VB12) pg/mL 120 98.1 – 142 151 135 – 167
SIEMENS ADVIA CENTAUR SYSTEMS
Carbamazepine (CARB) µg/mL 2.71 2.06 – 3.35 14.4 12.0 – 16.9
Cortisol (COR) µg/dL 10.1 6.65 – 13.5 40.7 37.7 – 43.7
Digoxin (DIG) ng/mL 1.30 0.874 – 1.73 3.35 2.77 – 3.94
Gentamicin (GENT) µg/mL 1.23 0.767 – 1.68 8.15 7.10 – 9.19
Phenobarbital (PHNB) µg/mL 15.5 10.4 – 20.6 53.2 41.7 – 64.7
Phenytoin (PHTN) µg/mL 11.5 8.82 – 14.1 28.9 22.5 – 35.2
T3 (Total) (T3) ng/mL 0.804 0.689 – 0.919 4.15 3.91 – 4.38
T3 Uptake/T Uptake (TUp) T Uptake Unit 0.918 0.884 – 0.953 1.71 1.61 – 1.82
T4 (Free) (FT4) ng/dL 1.15 0.989 – 1.30 6.14 5.73 – 6.56
T4 (Total) (T4) µg/dL 6.39 4.87 – 7.91 24.2 18.9 – 29.5
Theophylline (THEO2) µg/mL 8.83 8.29 – 9.38 23.6 22.4 – 24.8
Thyroid Stimulating Hormone (TSH) µIU/mL 1.97 1.29 – 2.65 22.4 18.7 – 26.1
Thyroid Stimulating Hormone (TSH) (TSH3UL) µIU/mL 1.40 0.848 – 1.94 14.7 11.1 – 18.2
Valproic Acid (VALP) µg/mL 37.1 28.7 – 45.6 123 102 – 144
Vancomycin (VANC) µg/mL 5.12 3.69 – 6.54 24.7 20.9 – 28.4
Vitamin B12 (VB12) pg/mL 91.6 <45.0 – 143 114 66.6 – 162
SIEMENS ADVIA CHEMISTRY SYSTEMS
Acetaminophen (Enzymatic) (ACET) µg/mL 17.9 14.5 – 21.3 78.5 63.3 – 93.6
Albumin (Bromcresol green) (ALB, ALB_c) g/dL 4.14 3.87 – 4.41 2.75 2.55 – 2.95
Albumin (Bromcresol Purple (BCP)) (ALBP) g/dL 3.87 3.53 – 4.21 2.52 2.26 – 2.77
Alkaline Phosphatase (ALPDEA) (2) U/L 157 134 – 181 539 458 – 620
Alkaline Phosphatase (IFCC) (ALP_2c) (2) U/L 107 80.8 – 133 420 373 – 467
ALT/SGPT (ALT, ALT_c) (2) U/L 29.6 22.7 – 36.4 103 91.3 – 115
ALT/SGPT (ALTP5P, ALTP_c) (2) U/L 31.2 24.7 – 37.7 107 95.7 – 117
Amylase (Ethylidene blocked-pNPG7) (AMYLAS) (2) U/L 78.7 69.8 – 87.5 416 363 – 468
Amylase (Pancreatic) (PAMY) (2) U/L 46.0 34.6 – 57.3 389 358 – 419
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
SIEMENS ADVIA CHEMISTRY SYSTEMS (terus menerus)
AST/SGOT (AST, AST_c) (2) U/L 41.2 33.5 – 48.8 208 187 – 229
AST/SGOT (ASTP5P, ASTP_c) (2) U/L 39.5 30.0 – 49.0 214 191 – 237
Bilirubin (Direct) (Vanadate Oxidation) (DBIL_2) mg/dL 0.363 0.265 – 0.461 1.41 1.10 – 1.72
Bilirubin (Total) (Vanadate Oxidation) (TBIL_2) mg/dL 1.01 0.871 – 1.14 4.53 4.02 – 5.03
Calcium (Arsenazo III) (CA_2, CA_2c) mg/dL 9.49 8.77 – 10.2 11.8 10.9 – 12.6
Calcium (CA, CA_c) mg/dL 8.99 8.31 – 9.68 12.1 11.2 – 13.0
Carbamazepine (EIA) (CARB_2) µg/mL 3.06 2.49 – 3.64 14.8 12.5 – 17.1
Carbon Dioxide (CO2) (Enzymatic) (CO2_L, CO2_c) mEq/L 31.7 23.9 – 39.4 19.1 13.5 – 24.7
Chloride (ISE indirect) (CL) mEq/L 103 96.8 – 109 86.2 80.9 – 91.4
Cholesterol (HDL) (Direct measure) (DHDL) (7) mg/dL 60.2 50.2 – 70.2 25.1 20.9 – 29.3
Cholesterol (LDL) (Direct measure) (DLDL) mg/dL 149 123 – 175 64.6 51.4 – 77.8
Cholesterol (Total) (CHOL_2, CHOL_c) mg/dL 243 225 – 260 107 98.4 – 116
Cholinesterase (Butyrylthiocholine (Trinder)) (CHE) (2) U/L 8804 8189 – 9419 4915 4491 – 5339
Creatine Kinase (CK) (CK_L) (2) U/L 136 116 – 157 459 390 – 528
Creatine Kinase (CK) (CKNAC) (2) U/L § §
Creatine Kinase (CK) (IFCC) (CKNAC) (2) U/L 134 118 – 151 447 396 – 497
Creatinine (Enzymatic) (ECRE_2) mg/dL 1.76 1.55 – 1.96 5.22 4.78 – 5.66
Creatinine (Jaffe) (CREA, CREA_2, CRE_2c) mg/dL 2.29 1.94 – 2.65 5.45 4.98 – 5.92
Digoxin (Immunoturbidimetric) (DIG) ng/mL 1.20 0.771 – 1.64 3.25 2.91 – 3.59
Gamma Glutamyltransferase (GGT) (IFCC) (2) U/L 60.5 42.6 – 78.4 159 122 – 196
Gentamicin (EIA) (GENT_2) µg/mL 1.33 1.28 – 1.39 6.21 5.50 – 6.92
Glucose (GLUH, GLUH_3, GLUH_c) mg/dL 79.2 70.4 – 87.9 267 245 – 289
Glucose (GLUO, GLUO_2) mg/dL 84.8 73.9 – 95.7 273 247 – 299
Immunoglobulin A (IgA) (IGA_2) mg/dL 223 151 – 296 141 102 – 180
Immunoglobulin G (IgG) (IGG_2) mg/dL 966 842 – 1090 591 321 – 861
Immunoglobulin M (IgM) (IGM_2) mg/dL 84.4 71.6 – 97.2 46.8 35.3 – 58.3
Iron (Ferrozine-no deproteinization) (IRON_2) µg/dL 229 214 – 243 66.6 59.1 – 74.0
Iron (TIBC) (TIBC) µg/dL 345 307 – 384 247 215 – 278
Lactate (Lactic Acid) (Lactate to pyruvate) (LAC) mg/dL 38.6 34.9 – 42.2 7.96 6.97 – 8.96
Lactate Dehydrogenase (LDH) (LDLP) (IFCC) (2) U/L 175 156 – 195 386 347 – 426
Lactate Dehydrogenase (LDH) (LDPL) (2) U/L 327 249 – 405 781 644 – 918
Lipase (Enzymatic, colorimetric) (LIP) (2) U/L 55.1 44.7 – 65.4 97.7 83.2 – 112
Lithium (Colorimetric) (LITH) mEq/L 0.537 0.397 – 0.677 1.84 1.63 – 2.05
Magnesium (Xylidyl blue) (MG, MG_c) mg/dL 2.01 1.72 – 2.30 4.36 3.80 – 4.92
Phenobarbital (EIA) (PHNB_2) µg/mL 13.5 7.45 – 19.6 50.2 37.1 – 63.3
Phenytoin (EIA) (PHYN_2) µg/mL 10.0 6.80 – 13.3 24.3 17.6 – 30.9
Phosphorus (IP, IP_c) mg/dL 3.36 3.00 – 3.72 7.48 6.93 – 8.02
Potassium (ISE indirect) (K) mEq/L 3.97 3.69 – 4.25 6.33 5.98 – 6.68
Protein Serum (Total) (TP, TP_c) g/dL 6.46 6.01 – 6.92 4.18 3.84 – 4.51
Salicylate (Enzymatic) (SAL) mg/dL 6.38 4.47 – 8.30 15.0 13.4 – 16.6
Sodium (ISE indirect) (NA) mEq/L 146 140 – 152 127 121 – 132
Theophylline (EIA) (THEO_2) µg/mL 8.66 6.90 – 10.4 25.2 20.0 – 30.5
Tobramycin (EIA) (TOB_2) µg/mL 6.66 5.74 – 7.58 1.69 1.30 – 2.09
Transferrin (Immunoturbidimetric) (TRF) mg/dL 251 218 – 284 171 149 – 193
Triglycerides (Enzymatic, end point) (TRIG) mg/dL 183 168 – 199 101 89.5 – 113
Urea Nitrogen (BUN) (Urease, UV) (UN, UN_c) (5) mg/dL 15.6 13.9 – 17.3 46.3 42.6 – 50.1
Uric Acid (Uricase, colorimetric) (UA, UA_c) mg/dL 4.88 4.50 – 5.26 9.46 8.86 – 10.1
Valproic Acid (EIA) (VPA_2) µg/mL 37.9 21.0 – 54.8 130 94.7 – 166
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
SIEMENS ADVIA CHEMISTRY SYSTEMS (terus menerus)
Vancomycin (EIA) (VANC_2) µg/mL 7.15 5.65 – 8.65 26.6 22.4 – 30.7
SIEMENS AUTOPAK AS-1 SYSTEMS (4)
Albumin (Bromcresol green) g/dL
ALT/SGPT (UV without P5P) (2) U/L
Amylase (CNP-G3) (2) U/L
AST/SGOT (UV without P5P) (2) U/L
Bilirubin (Total) (Jendrassik Grof) mg/dL
Calcium (o-cresolphthalein complexone) mg/dL
Cholesterol (HDL) (Direct measure, immunoinhibition) (DHDL) (7) mg/dL
Cholesterol (LDL) (Direct measure) (DLDL) mg/dL
Cholesterol (Total) (CHOL) mg/dL
Cholesterol (Total) (Liq. CHOL) mg/dL
Creatinine (CRTN) mg/dL
Glucose (GLUC) mg/dL
Protein Serum (Total) (TPR) g/dL
Triglycerides (Liq. TRIG) mg/dL
Urea Nitrogen (BUN) (5) mg/dL
Uric Acid mg/dL
SIEMENS BN SERIES NEPHELOMETERS
Alpha 1-Antitrypsin mg/dL 142 117 – 167 94.3 75.3 – 113
Apolipoprotein A-I mg/dL 127 122 – 133 84.2 79.3 – 89.1
Apolipoprotein B mg/dL 73.5 63.3 – 83.7 45.7 34.8 – 56.6
Ceruloplasmin mg/dL 28.6 26.3 – 30.9 18.4 18.0 – 18.9
Complement C3 mg/dL 154 147 – 161 96.0 93.2 – 98.8
Immunoglobulin A (IgA) mg/dL 217 203 – 230 131 124 – 138
Immunoglobulin G (IgG) mg/dL 983 916 – 1050 601 559 – 644
Immunoglobulin M (IgM) mg/dL 103 87.3 – 118 50.1 41.8 – 58.5
SIEMENS DIMENSION SERIES
Acetaminophen (Enzymatic, colorimetric) µg/mL 22.6 17.3 – 27.9 94.8 85.9 – 104
Alkaline Phosphatase (IFCC ALPI) (2) U/L 109 67.4 – 151 431 268 – 593
ALT/SGPT (IFCC ALTI) (2) U/L 34.4 26.4 – 42.4 107 89.2 – 126
AST/SGOT (2) U/L 42.1 34.1 – 50.2 209 183 – 234
AST/SGOT (IFCC 2002 Correlated) (2) U/L 42.2 34.1 – 50.2 209 184 – 234
Bilirubin (Direct) (Diazotization) (DBI) mg/dL 0.209 0.095 – 0.323 0.865 0.670 – 1.06
Bilirubin (Total) (Jendrassik Grof) (TBI) mg/dL 0.864 0.652 – 1.08 4.07 3.61 – 4.53
Calcium mg/dL 9.18 8.31 – 10.0 12.4 11.4 – 13.5
Carbamazepine µg/mL 2.74 2.04 – 3.44 14.3 11.8 – 16.8
Chloride (EXL/Xpand) mEq/L 122 109 – 135 101 89.2 – 112
Chloride (RxL) mEq/L § §
Cholesterol (HDL) (DF48B) (7) mg/dL 57.7 45.3 – 70.2 25.1 19.0 – 31.2
Cholesterol (LDL) (ALDL) mg/dL 136 115 – 158 62.7 51.9 – 73.5
Cholesterol (Total) mg/dL 242 216 – 269 91.9 78.5 – 105
Creatine Kinase (CK) (IFCC CKI) (2) U/L 135 114 – 156 427 381 – 474
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
SIEMENS DIMENSION SERIES (terus menerus)
Creatinine (CRE2) mg/dL 2.60 2.18 – 3.03 6.06 5.32 – 6.81
Creatinine (EZCR) mg/dL 2.71 2.07 – 3.35 6.19 5.18 – 7.20
Digoxin (EIA) ng/mL 0.780 0.519 – 1.04 2.49 2.07 – 2.90
Gamma Glutamyltransferase (GGT) (IFCC 2002 Correlated) (2) U/L 65.4 52.4 – 78.5 159 133 – 186
Glucose (Hexokinase) mg/dL 91.2 81.9 – 100 280 255 – 306
Immunoglobulin A (IgA) mg/dL 191 162 – 219 122 96.9 – 146
Immunoglobulin M (IgM) mg/dL 73.5 56.7 – 90.2 42.3 26.9 – 57.7
Iron (Ferene) µg/dL 229 209 – 248 65.5 55.3 – 75.7
Iron (TIBC) (IBCT) µg/dL 316 265 – 366 190 151 – 229
Lactate Dehydrogenase (LDH) (IFCC LDI) (2) U/L 165 127 – 202 359 289 – 429
Lipase (Colorimetric) (2) U/L 199 164 – 234 311 266 – 357
Magnesium mg/dL 2.03 1.70 – 2.36 4.38 3.90 – 4.85
Phenobarbital µg/mL 13.5 9.07 – 18.0 45.7 35.7 – 55.6
Phenytoin µg/mL 10.6 7.84 – 13.3 26.8 21.8 – 31.8
Phosphorus (DF61A) mg/dL 3.54 3.15 – 3.93 7.53 6.92 – 8.13
Potassium (EXL/Xpand) mEq/L 3.81 3.53 – 4.09 6.29 5.84 – 6.73
Potassium (RxL) mEq/L § §
Salicylate (Trinder) mg/dL 7.95 6.61 – 9.29 10.6 8.91 – 12.2
Sodium (EXL/Xpand) mEq/L 142 134 – 151 125 118 – 133
Sodium (RxL) mEq/L § §
T3 Uptake/T Uptake (EIA) % Uptake 37.7 16.4 – 59.0 56.2 46.3 – 66.0
T4 (Free) ng/dL § §
T4 (Free) (Chemiluminescence) ng/dL 0.942 0.843 – 1.04 6.89 – >8.00
T4 (Total) (EIA) µg/dL 7.68 5.81 – 9.54 20.3 15.4 – >24.0
Theophylline µg/mL 8.50 6.73 – 10.3 25.1 19.9 – 30.4
Thyroid Stimulating Hormone (TSH) (Chemiluminescence) µIU/mL 1.48 1.28 – 1.68 16.5 14.4 – 18.6
Thyroid Stimulating Hormone (TSH) (EIA) µIU/mL 1.26 0.793 – 1.72 15.1 11.3 – 18.8
Tobramycin µg/mL 8.05 6.34 – 9.75 1.62 1.02 – 2.22
Transferrin mg/dL § §
Uric Acid (Uricase, UV) mg/dL 4.72 4.23 – 5.20 9.02 8.26 – 9.78
Valproic Acid µg/mL 35.2 29.1 – 41.2 111 90.6 – 130
Vancomycin µg/mL 7.35 5.80 – 8.90 30.8 26.3 – 35.3
SIEMENS DIMENSION VISTA SYSTEMS
Acetaminophen µg/mL 23.9 18.8 – 29.1 96.3 87.7 – 105
AFP ng/mL 2.66 2.44 – 2.87 1.90 1.72 – 2.08
Alkaline Phosphatase (IFCC ALPI) (2) U/L 117 99.5 – 135 445 398 – 492
Alpha 1-Antitrypsin mg/dL 139 129 – 150 94.0 84.0 – 104
ALT/SGPT (IFCC ALTI) (2) U/L 31.2 26.2 – 36.3 97.3 89.2 – 105
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
SIEMENS DIMENSION VISTA SYSTEMS (terus menerus)
Apolipoprotein A-I mg/dL 145 124 – 166 89.4 81.0 – 97.8
Apolipoprotein B mg/dL 78.9 69.8 – 88.1 47.8 41.4 – 54.2
AST/SGOT (2) U/L 41.4 32.4 – 50.5 212 192 – 231
Bilirubin (Total) (Jendrassik Grof) mg/dL 0.900 0.787 – 1.01 4.18 3.79 – 4.58
Calcium mg/dL 8.96 8.37 – 9.55 11.9 11.2 – 12.5
Carbamazepine µg/mL 2.82 2.18 – 3.46 14.1 11.7 – 16.4
CEA ng/mL 0.896 0.815 – 0.977 0.744 0.623 – 0.865
Ceruloplasmin mg/dL 30.3 27.4 – 33.2 20.1 19.0 – 21.2
Cholesterol (HDL) (HDLC) (7) mg/dL 59.4 48.7 – 70.2 27.0 21.3 – 32.6
Cholesterol (LDL) (ALDL) mg/dL 142 115 – 170 62.1 47.9 – 76.3
Cholesterol (Total) mg/dL 245 224 – 265 98.8 87.6 – 110
Complement C3 mg/dL 143 130 – 157 93.0 83.1 – 103
Creatine Kinase (CK) (IFCC CKI) (2) U/L 137 112 – 162 427 373 – 481
Creatinine (CRE2) mg/dL 2.68 2.30 – 3.05 6.15 5.48 – 6.82
Creatinine (ECREA) mg/dL
Digoxin (Chemiluminescence) ng/mL 1.37 1.28 – 1.45 3.49 3.37 – 3.61
Gentamicin µg/mL 1.44 0.984 – 1.90 6.81 5.91 – 7.71
hCG mIU/mL 68.9 65.4 – 72.5 82.7 77.8 – 87.5
Immunoglobulin A (IgA) mg/dL 209 179 – 240 135 109 – 162
Immunoglobulin M (IgM) mg/dL 95.8 77.9 – 114 50.7 38.3 – 63.0
Iron (Ferene) µg/dL 230 210 – 249 65.8 53.4 – 78.2
Iron (TIBC) µg/dL 339 289 – 390 212 172 – 252
Lactate (Lactic Acid) mg/dL 40.9 35.7 – 46.1 10.1 8.41 – 11.7
Lactate Dehydrogenase (LDH) (IFCC LDI) (2) U/L 167 128 – 206 366 309 – 423
Lipase (Colorimetric) (2) U/L 195 160 – 230 330 282 – 378
Magnesium mg/dL 2.30 1.98 – 2.62 4.76 4.32 – 5.21
Phenobarbital µg/mL 13.6 9.21 – 17.9 45.6 35.9 – 55.3
Phenytoin µg/mL 11.4 9.32 – 13.5 26.8 21.8 – 31.8
Phosphorus mg/dL 3.27 3.00 – 3.53 7.50 6.84 – 8.17
Salicylate (Trinder) mg/dL 7.68 6.89 – 8.48 12.3 11.1 – 13.5
T3 (Free) (Chemiluminescence) pg/mL 2.80 2.44 – 3.16 16.0 12.9 – 19.1
T3 Uptake/T Uptake (EIA) % Uptake 36.8 16.0 – 57.6 54.8 45.3 – >58.0
T4 (Free) (Chemiluminescence) ng/dL 0.948 0.868 – 1.03 7.78 7.21 – >8.00
T4 (Total) (EIA) µg/dL 9.59 7.20 – 12.0 18.2 – >24.0
Theophylline µg/mL 8.38 6.63 – 10.1 23.0 18.0 – 27.9
Thyroid Stimulating Hormone (TSH) µIU/mL 1.35 1.28 – 1.42 16.2 15.0 – 17.4
8
INSTRUMEN
Level 1 - 26461 Level 2 - 26462
SIEMENS DIMENSION VISTA SYSTEMS (terus menerus)
Tobramycin µg/mL 7.52 5.84 – 9.21 1.55 0.947 – 2.15
Transferrin mg/dL 245 218 – 272 164 149 – 179
Triglycerides (Enzymatic, end point) mg/dL 194 172 – 215 108 93.7 – 122
Uric Acid (Uricase, UV) mg/dL 4.76 4.54 – 4.99 9.14 8.73 – 9.55
Valproic Acid µg/mL 42.5 34.0 – 50.9 121 98.5 – 144
Vancomycin µg/mL 7.65 6.03 – 9.27 30.5 26.0 – 35.1
Vitamin B12 pg/mL 299 236 – 362 269 216 – 321
SIEMENS IMMULITE / IMMULITE 1000
T4 (Total) µg/dL 6.71 5.57 – 7.84 19.2 17.5 – 20.9
Thyroid Stimulating Hormone (TSH) (Gen. 3) µIU/mL 1.56 1.36 – 1.75 15.2 12.9 – 17.5
SIEMENS IMMULITE 2000 / 2000 XPi
Cortisol µg/dL 9.28 6.63 – 11.9 35.3 29.8 – 40.9
T3 (Total) ng/dL 72.2 45.6 – 98.8 393 307 – 479
T4 (Total) µg/dL 6.68 5.44 – 7.91 19.6 16.8 – 22.3
Thyroid Stimulating Hormone (TSH) (Gen. 3) µIU/mL 1.63 1.14 – 2.11 16.4 13.3 – 19.5
Thyroid Stimulating Hormone (TSH) (Rapid TSH) µIU/mL 1.67 1.21 – 2.13 16.4 13.1 – 19.8
CATATAN KAKI
(1) Semua catatan kaki bisa jadi tidak berlaku pada grafik data pilihan Anda.
(2) Nilai-nilai diperoleh pada suhu 37°C.
(3) Nilai rata-rata dihitung dari data yang dihasilkan oleh instrumen-instrumen yang menggunakan metode ini.
(4) Nilai yang ditetapkan tersebut ditentukan menggunakan protokol dari pabrik pembuat reagensia dan/atau instrumen dan tidak menggambarkan kisaran ±3SD.
(5) mg/dL urea nitrogen x 2,14 = mg/dL Urea. Rentang nilai Unit S.I. dinyatakan sebagai Urea.
(6) Produk ini telah diuji dengan menggunakan metodologi yang tercantum dalam brosur kemasan. Kinerja produk ini belum dievaluasi untuk digunakan dengan
metode elektroforesis kapiler.
(7) Hanya metode langsung.
(8) % Protein Total
Data tidak tersedia pada saat ini. Harap tanyakan.
§ Data yang dibutuhkan untuk menentukan nilai rata-rata dan rentang nilai keberterimaan pada pengujian uji ini tidak diperoleh karena peserta yang terbatas.
Jika laboratorium Anda berminat untuk berperan serta dalam Program Penetapan Nilai untuk pengujian ini, silahkan menghubungi kantor Bio-Rad setempat.

Lyphochek Assayed Chemistry Control Levels 1 and 2: Tanggal Revisi 2020-06-15 Menunjukkan Informasi Yang Direvisi

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Lyphochek Assayed Chemistry Control Levels 1 and 2: Tanggal Revisi 2020-06-15 Menunjukkan Informasi Yang Direvisi

Uploaded by

Copyright:

Available Formats

Lyphochek® Assayed Chemistry Control

Tanggal Revisi 2020-06-15 Menunjukkan Informasi yang Direvisi

Halaman 1 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 2 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 3 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 4 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 5 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 6 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 7 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 8 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 9 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 10 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 11 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 12 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 13 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 14 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 15 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 16 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 17 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 18 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 19 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 20 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 21 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 22 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 23 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 24 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 25 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

Halaman 26 BAHASA INDONESIA/Indonesian • 2019-05 • 4030-00

You might also like